<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><front><journal-meta><journal-id journal-id-type="nlm-ta">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="iso-abbrev">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="publisher-id">ECAM</journal-id><journal-title-group><journal-title>Evidence-based Complementary and Alternative Medicine : eCAM</journal-title></journal-title-group><issn pub-type="ppub">1741-427X</issn><issn pub-type="epub">1741-4288</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19729492</article-id><article-id pub-id-type="pmc">3135864</article-id><article-id pub-id-type="doi">10.1093/ecam/nep125</article-id><article-id pub-id-type="publisher-id">nep125</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Influence of Craniosacral Therapy on Anxiety, Depression and Quality of Life in Patients with Fibromyalgia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Matarán-Peñarrocha</surname><given-names>Guillermo A.</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Castro-Sánchez</surname><given-names>Adelaida María</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>García</surname><given-names>Gloria Carballo</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Moreno-Lorenzo</surname><given-names>Carmen</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Carreño</surname><given-names>Tesifón Parrón</given-names></name><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zafra</surname><given-names>María Dolores Onieva</given-names></name><xref ref-type="aff" rid="I5">
<sup>5</sup>
</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>La Vega Sanitary District (Andalusian Health Public Service), Department of Physical Therapy, University of Granada, Spain</aff><aff id="I2"><sup>2</sup>Department of Physical Therapy, University of Almería, Spain</aff><aff id="I3"><sup>3</sup>Department of Psychology, University of Granada, Spain</aff><aff id="I4"><sup>4</sup>Department of Neurosciences, University of Almería, Spain</aff><aff id="I5"><sup>5</sup>Department of Nursing and Physical Therapy, University of Almería (UAL), Spain</aff><author-notes><corresp id="cor1">*Guillermo A. Matarán-Peñarrocha: <email>lemur@correo.ugr.es</email></corresp></author-notes><pub-date pub-type="ppub"><year>2011</year></pub-date><pub-date pub-type="epub"><day>15</day><month>6</month><year>2011</year></pub-date><volume>2011</volume><elocation-id>178769</elocation-id><history><date date-type="received"><day>19</day><month>5</month><year>2009</year></date><date date-type="accepted"><day>22</day><month>7</month><year>2009</year></date></history><permissions><copyright-statement>Copyright © 2011 Guillermo A. Matarán-Peñarrocha et al.</copyright-statement><copyright-year>2011</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/3.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p><offsets xml_i="3850" xml_f="5145" txt_i="11" txt_f="1306">Fibromyalgia is considered as a combination of physical, psychological and social disabilities. The causes of pathologic mechanism underlying fibromyalgia are unknown, but fibromyalgia may lead to reduced quality of life. The objective of this study was to analyze the repercussions of craniosacral therapy on depression, anxiety and quality of life in fibromyalgia patients with painful symptoms. An experimental, double-blind longitudinal clinical trial design was undertaken. Eighty-four patients diagnosed with fibromyalgia were randomly assigned to an intervention group (craniosacral therapy) or placebo group (simulated treatment with disconnected ultrasound). The treatment period was 25 weeks. Anxiety, pain, sleep quality, depression and quality of life were determined at baseline and at 10 minutes, 6 months and 1-year post-treatment. State anxiety and trait anxiety, pain, quality of life and Pittsburgh sleep quality index were significantly higher in the intervention versus placebo group after the treatment period and at the 6-month follow-up. However, at the 1-year follow-up, the groups only differed in the Pittsburgh sleep quality index. Approaching fibromyalgia by means of craniosacral therapy contributes to improving anxiety and quality of life levels in these patients.</offsets></p></abstract></article-meta></front><body><sec id="sec1"><title><offsets xml_i="5211" xml_f="5226" txt_i="1314" txt_f="1329">1. Introduction</offsets></title><p><offsets xml_i="5237" xml_f="5491" txt_i="1330" txt_f="1584">There is an increasing interest in the role of psychological factors in fibromyalgia, and studies have been published on associated psychological variables, psychopathological explanations, assessment instruments and psychological intervention programs [</offsets><xref rid="B1" ref-type="bibr"><offsets xml_i="5522" xml_f="5523" txt_i="1584" txt_f="1585">1</offsets></xref><offsets xml_i="5530" xml_f="5532" txt_i="1585" txt_f="1587">, </offsets><xref rid="B2" ref-type="bibr"><offsets xml_i="5563" xml_f="5564" txt_i="1587" txt_f="1588">2</offsets></xref><offsets xml_i="5571" xml_f="5728" txt_i="1588" txt_f="1745">]. Suhr (2003) considered psychological factors to be important for understanding the subjective and objective cognitive disorders of fibromyalgia patients [</offsets><xref rid="B3" ref-type="bibr"><offsets xml_i="5759" xml_f="5760" txt_i="1745" txt_f="1746">3</offsets></xref><offsets xml_i="5767" xml_f="6124" txt_i="1746" txt_f="2103">]. Various investigations have centered on the relationship of fibromyalgia with pain, depression, anxiety and quality of life. The Copenhagen declaration in 1992 described psychological patterns frequently associated with fibromyalgia, such as anxiety and depression, and there is a growing interest in this aspect among professionals of different fields [</offsets><xref rid="B4" ref-type="bibr"><offsets xml_i="6155" xml_f="6156" txt_i="2103" txt_f="2104">4</offsets></xref><offsets xml_i="6163" xml_f="6353" txt_i="2104" txt_f="2294">]. Nevertheless, many authors consider that psychological factors are more frequently the result than the cause of pain and disability in fibromyalgia, and this issue remains controversial [</offsets><xref rid="B4" ref-type="bibr"><offsets xml_i="6384" xml_f="6385" txt_i="2294" txt_f="2295">4</offsets></xref><offsets xml_i="6392" xml_f="6394" txt_i="2295" txt_f="2297">].</offsets></p><p><offsets xml_i="6401" xml_f="6592" txt_i="2298" txt_f="2489">Some symptoms of fibromyalgia are similar to those observed during depression, and antidepressants have been administered to fibromyalgia patients to treat sleep disorders and pain symptoms [</offsets><xref rid="B4" ref-type="bibr"><offsets xml_i="6623" xml_f="6624" txt_i="2489" txt_f="2490">4</offsets></xref><offsets xml_i="6631" xml_f="6771" txt_i="2490" txt_f="2630">]. Review of the literature on the association between fibromyalgia and depression reveals two divergent research lines. Hudson and others [</offsets><xref rid="B5" ref-type="bibr"><offsets xml_i="6802" xml_f="6803" txt_i="2630" txt_f="2631">5</offsets></xref><offsets xml_i="6810" xml_f="6939" txt_i="2631" txt_f="2760">] believe that a direct association cannot be established between fibromyalgia and depression, whereas Gruber and others (1996) [</offsets><xref rid="B6" ref-type="bibr"><offsets xml_i="6970" xml_f="6971" txt_i="2760" txt_f="2761">6</offsets></xref><offsets xml_i="6978" xml_f="7383" txt_i="2761" txt_f="3166">] propose a common etiology for fibromyalgia and depression. Significant differences in psychological state between patients with fibromyalgia and depression were reported in a study on fibromyalgia, pain intensity and duration and psychological alterations; the results of depression and anxiety questionnaires indicated that the somatic expression of depression differed between the two patient groups [</offsets><xref rid="B7" ref-type="bibr"><offsets xml_i="7414" xml_f="7415" txt_i="3166" txt_f="3167">7</offsets></xref><offsets xml_i="7422" xml_f="7642" txt_i="3167" txt_f="3387">]. The relationship between depression and fibromyalgia remains controversial. Although antidepressants can reduce pain and fatigue in fibromyalgia, the effects of these drugs vary in degree and duration among patients [</offsets><xref rid="B7" ref-type="bibr"><offsets xml_i="7673" xml_f="7674" txt_i="3387" txt_f="3388">7</offsets></xref><offsets xml_i="7681" xml_f="7683" txt_i="3388" txt_f="3390">].</offsets></p><p><offsets xml_i="7690" xml_f="7902" txt_i="3391" txt_f="3603">Various authors have indicated that patients with fibromyalgia are more depressed than healthy controls and that their perception of psychological distress or depression is similar to that of depressed patients [</offsets><xref rid="B8" ref-type="bibr"><offsets xml_i="7933" xml_f="7934" txt_i="3603" txt_f="3604">8</offsets></xref><offsets xml_i="7941" xml_f="7943" txt_i="3604" txt_f="3606">, </offsets><xref rid="B9" ref-type="bibr"><offsets xml_i="7974" xml_f="7975" txt_i="3606" txt_f="3607">9</offsets></xref><offsets xml_i="7982" xml_f="8153" txt_i="3607" txt_f="3778">]. Moreover, levels of psychological distress (depression, anxiety) have been correlated with cognitive findings in both groups of patients (fibromyalgia and depression) [</offsets><xref rid="B10" ref-type="bibr"><offsets xml_i="8185" xml_f="8187" txt_i="3778" txt_f="3780">10</offsets></xref><offsets xml_i="8194" xml_f="8195" txt_i="3780" txt_f="3781">–</offsets><xref rid="B12" ref-type="bibr"><offsets xml_i="8227" xml_f="8229" txt_i="3781" txt_f="3783">12</offsets></xref><offsets xml_i="8236" xml_f="8238" txt_i="3783" txt_f="3785">].</offsets></p><p><offsets xml_i="8245" xml_f="8254" txt_i="3786" txt_f="3795">Garland [</offsets><xref rid="B13" ref-type="bibr"><offsets xml_i="8286" xml_f="8288" txt_i="3795" txt_f="3797">13</offsets></xref><offsets xml_i="8295" xml_f="8938" txt_i="3797" txt_f="4440">] observed a higher degree of anxiety in fibromyalgia patients than in healthy controls or other groups of patients with painful disease, for example, rheumatoid arthritis. Anxious individuals usually have a respiratory dysfunction that generates more work in the upper chest, and the resulting minimum diaphragmatic activity may exacerbate symptoms in patients with fibromyalgia or chronic fatigue syndromes. Although anxiety is known to be an immediate symptom of hyperventilation, it is controversial whether or not hyperventilation and anxiety in patients with fibromyalgia result from a broader alteration. In this context, Peter et al. [</offsets><xref rid="B14" ref-type="bibr"><offsets xml_i="8970" xml_f="8972" txt_i="4440" txt_f="4442">14</offsets></xref><offsets xml_i="8979" xml_f="9128" txt_i="4442" txt_f="4591">] reported that education to reduce the effects of hyperventilation can reduce fibromyalgia symptoms, including pain, fatigue and emotional distress.</offsets></p><p><offsets xml_i="9135" xml_f="9460" txt_i="4592" txt_f="4917">Dysfunction of the autonomic nervous system may explain the different clinical manifestations of fibromyalgia. The hyperactive sympathetic nervous system of these patients becomes incapable of responding to different stressing stimuli, which would explain the continuous tiredness and the morning rigidity of these patients [</offsets><xref rid="B15" ref-type="bibr"><offsets xml_i="9492" xml_f="9494" txt_i="4917" txt_f="4919">15</offsets></xref><offsets xml_i="9501" xml_f="9661" txt_i="4919" txt_f="5079">]. Likewise, incessant sympathetic activity may explain the sleeping disorders, anxiety, pseudo Raynaud's phenomenon, dry syndrome and intestinal irritability [</offsets><xref rid="B2" ref-type="bibr"><offsets xml_i="9692" xml_f="9693" txt_i="5079" txt_f="5080">2</offsets></xref><offsets xml_i="9700" xml_f="9702" txt_i="5080" txt_f="5082">, </offsets><xref rid="B15" ref-type="bibr"><offsets xml_i="9734" xml_f="9736" txt_i="5082" txt_f="5084">15</offsets></xref><offsets xml_i="9743" xml_f="10129" txt_i="5084" txt_f="5470">]. The other defining characteristics of fibromyalgia such as diffuse pain, painful sensitivity to palpation and paresthesia may also be explained by “sympathetically maintained pain". This neuropathic pain is characterized by a perception of pain regardless of the presence of stimuli, accompanied by paresthesias and allodynia, which are characteristic of patients with fibromyalgia [</offsets><xref rid="B16" ref-type="bibr"><offsets xml_i="10161" xml_f="10163" txt_i="5470" txt_f="5472">16</offsets></xref><offsets xml_i="10170" xml_f="10172" txt_i="5472" txt_f="5474">].</offsets></p><p><offsets xml_i="10179" xml_f="10331" txt_i="5475" txt_f="5627">Patients frequently report sleeping disorders as well as depression, and both factors are known to have a strong association with cognitive disruption [</offsets><xref rid="B17" ref-type="bibr"><offsets xml_i="10363" xml_f="10365" txt_i="5627" txt_f="5629">17</offsets></xref><offsets xml_i="10372" xml_f="10374" txt_i="5629" txt_f="5631">, </offsets><xref rid="B18" ref-type="bibr"><offsets xml_i="10406" xml_f="10408" txt_i="5631" txt_f="5633">18</offsets></xref><offsets xml_i="10415" xml_f="10751" txt_i="5633" txt_f="5969">] and to play an important role in the reduced quality of life reported by fibromyalgia patients. There is a high prevalence of sleeping problems in this population. In many cases, pain and fatigue disappear with sleep. However, paradoxically, patients with fibromyalgia awake with intensified muscle rigidity, pain and marked fatigue [</offsets><xref rid="B19" ref-type="bibr"><offsets xml_i="10783" xml_f="10785" txt_i="5969" txt_f="5971">19</offsets></xref><offsets xml_i="10792" xml_f="10794" txt_i="5971" txt_f="5973">, </offsets><xref rid="B20" ref-type="bibr"><offsets xml_i="10826" xml_f="10828" txt_i="5973" txt_f="5975">20</offsets></xref><offsets xml_i="10835" xml_f="10853" txt_i="5975" txt_f="5993">]. Shaver et al. [</offsets><xref rid="B21" ref-type="bibr"><offsets xml_i="10885" xml_f="10887" txt_i="5993" txt_f="5995">21</offsets></xref><offsets xml_i="10894" xml_f="11010" txt_i="5995" txt_f="6111">] described a vicious circle of pain, poor sleep, fatigue and increased pain in overt fibromyalgia. Bigatti et al. [</offsets><xref rid="B22" ref-type="bibr"><offsets xml_i="11042" xml_f="11044" txt_i="6111" txt_f="6113">22</offsets></xref><offsets xml_i="11051" xml_f="11187" txt_i="6113" txt_f="6249">] concluded that sleep predicts subsequent pain in these patients but may be related to depression due to pain and physical dysfunction.</offsets></p><p><offsets xml_i="11194" xml_f="11405" txt_i="6250" txt_f="6461">The quality of life of patients with fibromyalgia is especially impaired in relation to physical function, intellectual activity and emotional state, influencing their working capacity and social relationships [</offsets><xref rid="B23" ref-type="bibr"><offsets xml_i="11437" xml_f="11439" txt_i="6461" txt_f="6463">23</offsets></xref><offsets xml_i="11446" xml_f="11458" txt_i="6463" txt_f="6475">]. Backman [</offsets><xref rid="B24" ref-type="bibr"><offsets xml_i="11490" xml_f="11492" txt_i="6475" txt_f="6477">24</offsets></xref><offsets xml_i="11499" xml_f="11840" txt_i="6477" txt_f="6818">] affirmed that psychosocial factors are related to two dimensions of experience: psychological (cognitive, affective) and social (interacting with others, performing daily activities). According to this author, psychosocial factors influence the perception of pain, which in turn influences psychological wellbeing and social participation.</offsets></p><p><offsets xml_i="11847" xml_f="11962" txt_i="6819" txt_f="6934">Various studies have demonstrated the efficacy of biofeedback acupuncture to reduce pain symptoms in fibromyalgia [</offsets><xref rid="B25" ref-type="bibr"><offsets xml_i="11994" xml_f="11996" txt_i="6934" txt_f="6936">25</offsets></xref><offsets xml_i="12003" xml_f="12004" txt_i="6936" txt_f="6937">–</offsets><xref rid="B28" ref-type="bibr"><offsets xml_i="12036" xml_f="12038" txt_i="6937" txt_f="6939">28</offsets></xref><offsets xml_i="12045" xml_f="12561" txt_i="6939" txt_f="7455">]. However, we could find no studies that address the effects of manual therapy on the autonomic nervous system or the possible benefit of this type of alternative therapies as a complement to pharmaceutical treatment of hyperautonomic alterations and derived disorders (anxiety and depression). With this background, the objective of this study was to determine the effects of craniosacral therapy on anxiety, depression, pain, sleep quality and quality of life in fibromyalgia patients up to 1-year post-treatment.</offsets></p></sec><sec id="sec2"><title><offsets xml_i="12593" xml_f="12603" txt_i="7457" txt_f="7467">2. Methods</offsets></title><sec sec-type="subsection" id="sec2.1"><title><offsets xml_i="12657" xml_f="12686" txt_i="7468" txt_f="7497">2.1. Setting and Participants</offsets></title><p><offsets xml_i="12697" xml_f="13275" txt_i="7498" txt_f="8076">Patients with fibromyalgia syndrome undergoing pharmaceutical therapy were recruited from among members of the Almeria Fibromyalgia Association with clinical records at the Torrecárdenas Hospital Complex (Almeria, Spain). Inclusion criteria were: diagnosis of fibromyalgia (by rheumatology specialist), age of 16–65 years and agreement to attend afternoon therapy sessions. Exclusion criteria were: presence of physical disease, psychological disease, infection, fever, hypotension or skin disorders or respiratory alterations that would limit the application of the treatments.</offsets></p><p><offsets xml_i="13282" xml_f="13576" txt_i="8077" txt_f="8371">Out of the 376 patients in the accessible population, 351 were subjected to a randomization procedure to recruit a sample of 119 patients. Out of these 119 patients, 15 were excluded, and the remaining 104 were randomly assigned by means of a balanced stratified assignment to an intervention (</offsets><italic><offsets xml_i="13584" xml_f="13585" txt_i="8371" txt_f="8372">n</offsets></italic><offsets xml_i="13594" xml_f="13613" txt_i="8372" txt_f="8391"> = 52) or placebo (</offsets><italic><offsets xml_i="13621" xml_f="13622" txt_i="8391" txt_f="8392">n</offsets></italic><offsets xml_i="13631" xml_f="14374" txt_i="8392" txt_f="9135"> = 52) group. The groups were balanced for type of medication received, sex and age, using a stratification system that generates a sequence of letters (from a table of correlatively ordered permutations) for each category and combination of categories. Informed consent was obtained from all participants according to the ethical criteria established in the Helsinki declaration, modified in 2000, for the performance of research projects. In Spain, current legislation for clinical trials is gathered in the Real Decreto 223/2004 February 6, 2004. This project was approved by the research commissions of the University of Almeria and of the Torrecárdenas Hospital Complex (Almeria)-Servicio Andaluz de Salud (Andalusian Healthcare Service).</offsets></p><p><offsets xml_i="14381" xml_f="14562" txt_i="9136" txt_f="9317">Twenty-one patients were under treatment with muscle relaxants, 32 with antidepressants, 46 with anxiolytics, 59 with anti-inflammatories, 36 with corticoids and 84 with analgesics.</offsets></p><sec sec-type="subsubsection" id="sec2.1.1"><title><offsets xml_i="14617" xml_f="14636" txt_i="9318" txt_f="9337">2.1.1. Measurements</offsets></title><p><offsets xml_i="14647" xml_f="14756" txt_i="9338" txt_f="9447">The following instruments were used to measure anxiety, depression and quality of life in study participants:</offsets></p><p><offsets xml_i="14763" xml_f="14764" txt_i="9448" txt_f="9449">
</offsets><list list-type="roman-lower"><list-item><p><offsets xml_i="14808" xml_f="14846" txt_i="9449" txt_f="9487">Visual analogue scale (VAS) for pain [</offsets><xref rid="B29" ref-type="bibr"><offsets xml_i="14878" xml_f="14880" txt_i="9487" txt_f="9489">29</offsets></xref><offsets xml_i="14887" xml_f="15022" txt_i="9489" txt_f="9624">]: This scale assesses the intensity of pain and degree of alleviation experienced by the patient (0 = no pain, 10 = unbearable pain) [</offsets><xref rid="B30" ref-type="bibr"><offsets xml_i="15054" xml_f="15056" txt_i="9624" txt_f="9626">30</offsets></xref><offsets xml_i="15063" xml_f="15065" txt_i="9626" txt_f="9628">].</offsets></p></list-item><list-item><p><offsets xml_i="15095" xml_f="15697" txt_i="9629" txt_f="10231">Short form-36 health survey (SF-36) for quality of life: The SF-36 survey evaluates dimensions of functional state, emotional wellbeing and health. Functional state dimensions are: physical function (10 items), social function (two items), role limitations due to physical problems (four items) and role limitations due to emotional problems (three items); emotional wellbeing dimensions are: mental health (five items), vitality (four items) and pain (two items); and health dimensions are: general health perception (five items) and change in health over time (one item—not included in final score) [</offsets><xref rid="B31" ref-type="bibr"><offsets xml_i="15729" xml_f="15731" txt_i="10231" txt_f="10233">31</offsets></xref><offsets xml_i="15738" xml_f="15740" txt_i="10233" txt_f="10235">].</offsets></p></list-item><list-item><p><offsets xml_i="15770" xml_f="16208" txt_i="10236" txt_f="10674">Pittsburgh Sleep Quality Index (PSQI): This questionnaire comprises 24 questions, 19 for subjects and 5 for individuals living with them. It yields scores for: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of hypnotic medication and daily dysfunction. Each component is scored on a scale of 0 to 3 (0 = no problem, 3 = severe problem), yielding an overall score range of 0–21 [</offsets><xref rid="B32" ref-type="bibr"><offsets xml_i="16240" xml_f="16242" txt_i="10674" txt_f="10676">32</offsets></xref><offsets xml_i="16249" xml_f="16251" txt_i="10676" txt_f="10678">].</offsets></p></list-item><list-item><p><offsets xml_i="16281" xml_f="16710" txt_i="10679" txt_f="11108">Assessment of the depression index (Beck depression inventory): The Beck inventory is a self-applied questionnaire of 21 items that assesses a broad spectrum of depressive symptoms. It gives weight to the cognitive component of depression, with symptoms in this area representing around 50% of the total questionnaire score. Out of the 21 items, 15 refer to ecological-cognitive symptoms, and six to somatic-vegetative symptoms [</offsets><xref rid="B33" ref-type="bibr"><offsets xml_i="16742" xml_f="16744" txt_i="11108" txt_f="11110">33</offsets></xref><offsets xml_i="16751" xml_f="16875" txt_i="11110" txt_f="11234">]. The score for each item ranges from 0–3 (from least to greatest severity), giving an overall score range of 0–63 points [</offsets><xref rid="B34" ref-type="bibr"><offsets xml_i="16907" xml_f="16909" txt_i="11234" txt_f="11236">34</offsets></xref><offsets xml_i="16916" xml_f="16918" txt_i="11236" txt_f="11238">].</offsets></p></list-item><list-item><p><offsets xml_i="16948" xml_f="17254" txt_i="11239" txt_f="11545">State Trait Anxiety Inventory (STAI): This 40-item questionnaire measures trait anxiety and state anxiety. For the trait anxiety scale (20 items), subjects describe how they feel in general, and for the state anxiety scale (20 items), how they feel at the present time. A score is obtained for each scale [</offsets><xref rid="B35" ref-type="bibr"><offsets xml_i="17286" xml_f="17288" txt_i="11545" txt_f="11547">35</offsets></xref><offsets xml_i="17295" xml_f="17297" txt_i="11547" txt_f="11549">].</offsets></p></list-item></list><offsets xml_i="17320" xml_f="17321" txt_i="11550" txt_f="11551">
</offsets></p></sec><sec sec-type="subsubsection" id="sec2.1.2"><title><offsets xml_i="17382" xml_f="17398" txt_i="11553" txt_f="11569">2.1.2. Procedure</offsets></title><p><offsets xml_i="17409" xml_f="17682" txt_i="11570" txt_f="11843">In this experimental, longitudinal double-blind clinical trial, the intervention group was formed by 43 patients and the placebo group by 41. Before the treatments, initial assessments of anxiety, depression, pain, sleep and quality of life were performed in all patients [</offsets><xref rid="B36" ref-type="bibr"><offsets xml_i="17714" xml_f="17716" txt_i="11843" txt_f="11845">36</offsets></xref><offsets xml_i="17723" xml_f="17931" txt_i="11845" txt_f="12053">]. Women of childbearing age were assessed the day after their menstrual period ended. These assessments were repeated at 30 min, six months and 1 year after the last session of the 25-week treatment program.</offsets></p></sec></sec><sec sec-type="subsection" id="sec2.2"><title><offsets xml_i="17993" xml_f="18010" txt_i="12056" txt_f="12073">2.2. Intervention</offsets></title><p><offsets xml_i="18021" xml_f="18550" txt_i="12074" txt_f="12603">The intervention group underwent a craniosacral therapy protocol, with two weekly sessions of 1 h for 25 weeks. The treatment was carried out by an expert craniosacral therapist with the patient in prone position. This therapy consists of applying very mild manual traction on cranial bones in flexion or extension stages of the craniosacral cycle. The aims were to contribute to re-establishing the normal movement of cranial bones and to intervene in the autonomic nervous system by releasing bone and membranous restrictions [</offsets><xref rid="B37" ref-type="bibr"><offsets xml_i="18582" xml_f="18584" txt_i="12603" txt_f="12605">37</offsets></xref><offsets xml_i="18591" xml_f="18877" txt_i="12605" txt_f="12891">]. Craniosacral therapy procedures were: still point (occipital), compression-decompression of temporomandibular joint, decompression of temporal fascia, compression-decompression of sphenobasilar joint, parietal lift, frontal lift, scapular waist release and pelvic diaphragm release [</offsets><xref rid="B37" ref-type="bibr"><offsets xml_i="18909" xml_f="18911" txt_i="12891" txt_f="12893">37</offsets></xref><offsets xml_i="18918" xml_f="18919" txt_i="12893" txt_f="12894">–</offsets><xref rid="B40" ref-type="bibr"><offsets xml_i="18951" xml_f="18953" txt_i="12894" txt_f="12896">40</offsets></xref><offsets xml_i="18960" xml_f="18962" txt_i="12896" txt_f="12898">].</offsets></p><p><offsets xml_i="18969" xml_f="19393" txt_i="12899" txt_f="13323">The placebo group underwent two weekly 30-min sessions of sham ultrasound treatment in which the disconnected probe (4 cm in diameter) was applied to the cervical area (10 min), lumbar region (10 min) and both sides of the knees (10 min). The sham treatment was performed with the patient in prone position. The screen of the ultrasound was covered to ensure that the patient was unaware that the equipment was disconnected.</offsets></p><p><offsets xml_i="19400" xml_f="19514" txt_i="13324" txt_f="13438">Both patient groups were instructed not to change their pharmacological treatment during the 25-week study period.</offsets></p></sec><sec sec-type="subsection" id="sec2.3"><title><offsets xml_i="19570" xml_f="19595" txt_i="13440" txt_f="13465">2.3. Statistical Analysis</offsets></title><p><offsets xml_i="19606" xml_f="19881" txt_i="13466" txt_f="13741">The SPSS package (version 17.0) was used for the data analyses. After performing descriptive statistics of variables at baseline, the Kolmogorov–Smirnof test was applied to evaluate the normal distribution of variables. Continuous data were expressed as means ± SD. A paired </offsets><italic><offsets xml_i="19889" xml_f="19890" txt_i="13741" txt_f="13742">t</offsets></italic><offsets xml_i="19899" xml_f="20526" txt_i="13742" txt_f="14369">-test was used to examine changes in scores between baseline and follow-up examinations. Inter-group differences in variables were analyzed by using repeated-measures analysis of variance. Relationships between demographic variables (sex and age group), aggravating factors, work activity, diseases related to fibromyalgia syndrome, VAS pain score, dimensions of the SF-36 health survey for quality of life, dimensions of the Pittsburgh sleep quality index, total Beck depression inventory score and state and trait anxiety scores were evaluated by calculating Pearson correlation coefficients. A 95% confidence interval (CI) (</offsets><italic><offsets xml_i="20534" xml_f="20535" txt_i="14369" txt_f="14370">α</offsets></italic><offsets xml_i="20544" xml_f="20581" txt_i="14370" txt_f="14407"> = 0.05) was considered in all tests.</offsets></p></sec></sec><sec id="sec3"><title><offsets xml_i="20619" xml_f="20629" txt_i="14410" txt_f="14420">3. Results</offsets></title><p><offsets xml_i="20640" xml_f="21055" txt_i="14421" txt_f="14836">During the study, 9 patients withdrew from the intervention group and 11 from the placebo group. Reasons for withdrawal were death of spouse, start of another type of treatment, change in pharmacologic therapy during treatment period, and missing sessions due to acute pain crisis and forgetfulness. The final study sample comprised 84 patients (81 females) aged 34–63 years with a mean age of 49.08 ± 14.17 years (</offsets><xref ref-type="fig" rid="fig1"><offsets xml_i="21087" xml_f="21095" txt_i="14836" txt_f="14844">Figure 1</offsets></xref><offsets xml_i="21102" xml_f="21203" txt_i="14844" txt_f="14945">). There were no differences in baseline demographic characteristics between the intervention group (</offsets><italic><offsets xml_i="21211" xml_f="21212" txt_i="14945" txt_f="14946">n</offsets></italic><offsets xml_i="21221" xml_f="21247" txt_i="14946" txt_f="14972"> = 43) and placebo group (</offsets><italic><offsets xml_i="21255" xml_f="21256" txt_i="14972" txt_f="14973">n</offsets></italic><offsets xml_i="21265" xml_f="21273" txt_i="14973" txt_f="14981"> = 41) (</offsets><xref ref-type="table" rid="tab1"><offsets xml_i="21307" xml_f="21314" txt_i="14981" txt_f="14988">Table 1</offsets></xref><offsets xml_i="21321" xml_f="21382" txt_i="14988" txt_f="15049">). The groups did not differ significantly in state anxiety (</offsets><italic><offsets xml_i="21390" xml_f="21391" txt_i="15049" txt_f="15050">P</offsets></italic><offsets xml_i="21400" xml_f="21428" txt_i="15050" txt_f="15075"> &lt; .320), trait anxiety (</offsets><italic><offsets xml_i="21436" xml_f="21437" txt_i="15075" txt_f="15076">P</offsets></italic><offsets xml_i="21446" xml_f="21466" txt_i="15076" txt_f="15093"> &lt; .269) or VAS (</offsets><italic><offsets xml_i="21474" xml_f="21475" txt_i="15093" txt_f="15094">P</offsets></italic><offsets xml_i="21484" xml_f="21593" txt_i="15094" txt_f="15200"> &lt; .239) scores but differed in all dimensions of the SF-36 questionnaire with the exception of vitality. </offsets></p><p><offsets xml_i="21600" xml_f="21710" txt_i="15201" txt_f="15311">In the whole study population, there were significant correlations at baseline between age and physical role (</offsets><italic><offsets xml_i="21718" xml_f="21719" txt_i="15311" txt_f="15312">r</offsets></italic><offsets xml_i="21728" xml_f="21738" txt_i="15312" txt_f="15322"> = 0.412; </offsets><italic><offsets xml_i="21746" xml_f="21747" txt_i="15322" txt_f="15323">P</offsets></italic><offsets xml_i="21756" xml_f="21795" txt_i="15323" txt_f="15362"> = .008), vitality and general health (</offsets><italic><offsets xml_i="21803" xml_f="21804" txt_i="15362" txt_f="15363">r</offsets></italic><offsets xml_i="21813" xml_f="21823" txt_i="15363" txt_f="15373"> = 0.433; </offsets><italic><offsets xml_i="21831" xml_f="21832" txt_i="15373" txt_f="15374">P</offsets></italic><offsets xml_i="21841" xml_f="21898" txt_i="15374" txt_f="15431"> = .005), habitual sleep efficiency and social function (</offsets><italic><offsets xml_i="21906" xml_f="21907" txt_i="15431" txt_f="15432">r</offsets></italic><offsets xml_i="21916" xml_f="21926" txt_i="15432" txt_f="15442"> = 0.319; </offsets><italic><offsets xml_i="21934" xml_f="21935" txt_i="15442" txt_f="15443">P</offsets></italic><offsets xml_i="21944" xml_f="21999" txt_i="15443" txt_f="15498"> = .045) and between mental health and emotional role (</offsets><italic><offsets xml_i="22007" xml_f="22008" txt_i="15498" txt_f="15499">r</offsets></italic><offsets xml_i="22017" xml_f="22027" txt_i="15499" txt_f="15509"> = 0.346; </offsets><italic><offsets xml_i="22035" xml_f="22036" txt_i="15509" txt_f="15510">P</offsets></italic><offsets xml_i="22045" xml_f="22071" txt_i="15510" txt_f="15536"> = .029), sleep duration (</offsets><italic><offsets xml_i="22079" xml_f="22080" txt_i="15536" txt_f="15537">r</offsets></italic><offsets xml_i="22089" xml_f="22099" txt_i="15537" txt_f="15547"> = 0.485; </offsets><italic><offsets xml_i="22107" xml_f="22108" txt_i="15547" txt_f="15548">P</offsets></italic><offsets xml_i="22117" xml_f="22157" txt_i="15548" txt_f="15588"> = .001) and habitual sleep efficiency (</offsets><italic><offsets xml_i="22165" xml_f="22166" txt_i="15588" txt_f="15589">r</offsets></italic><offsets xml_i="22175" xml_f="22185" txt_i="15589" txt_f="15599"> = 0.328; </offsets><italic><offsets xml_i="22193" xml_f="22194" txt_i="15599" txt_f="15600">P</offsets></italic><offsets xml_i="22203" xml_f="22212" txt_i="15600" txt_f="15609"> = .039).</offsets></p><sec sec-type="subsection" id="sec3.1"><title><offsets xml_i="22262" xml_f="22297" txt_i="15610" txt_f="15645">3.1. At 35 Weeks after Intervention</offsets></title><p><offsets xml_i="22308" xml_f="22394" txt_i="15646" txt_f="15732">At 35 weeks, the intervention group showed significant improvements in state anxiety (</offsets><italic><offsets xml_i="22402" xml_f="22403" txt_i="15732" txt_f="15733">P</offsets></italic><offsets xml_i="22412" xml_f="22443" txt_i="15733" txt_f="15761"> &lt; .029) and trait anxiety (</offsets><italic><offsets xml_i="22451" xml_f="22452" txt_i="15761" txt_f="15762">P</offsets></italic><offsets xml_i="22461" xml_f="22596" txt_i="15762" txt_f="15894"> &lt; .042) versus baseline scores. No changes were observed in the placebo group. The groups differed significantly in trait anxiety (</offsets><italic><offsets xml_i="22604" xml_f="22605" txt_i="15894" txt_f="15895">P</offsets></italic><offsets xml_i="22614" xml_f="22725" txt_i="15895" txt_f="16003"> &lt; .045). Depression scores did not differ significantly between groups or with respect to baseline values (</offsets><xref ref-type="fig" rid="fig2"><offsets xml_i="22757" xml_f="22765" txt_i="16003" txt_f="16011">Figure 2</offsets></xref><offsets xml_i="22772" xml_f="22775" txt_i="16011" txt_f="16014">). </offsets></p><p><offsets xml_i="22782" xml_f="22866" txt_i="16015" txt_f="16099">VAS-measured pain improved significantly in the intervention group versus baseline (</offsets><italic><offsets xml_i="22874" xml_f="22875" txt_i="16099" txt_f="16100">P</offsets></italic><offsets xml_i="22884" xml_f="22925" txt_i="16100" txt_f="16138"> &lt; .035) and differed between groups (</offsets><italic><offsets xml_i="22933" xml_f="22934" txt_i="16138" txt_f="16139">P</offsets></italic><offsets xml_i="22943" xml_f="23037" txt_i="16139" txt_f="16230"> &lt; .041). The intervention group also showed significant improvement in physical function (</offsets><italic><offsets xml_i="23045" xml_f="23046" txt_i="16230" txt_f="16231">P</offsets></italic><offsets xml_i="23055" xml_f="23083" txt_i="16231" txt_f="16256"> &lt; .024), physical role (</offsets><italic><offsets xml_i="23091" xml_f="23092" txt_i="16256" txt_f="16257">P</offsets></italic><offsets xml_i="23101" xml_f="23125" txt_i="16257" txt_f="16278"> &lt; .020), body pain (</offsets><italic><offsets xml_i="23133" xml_f="23134" txt_i="16278" txt_f="16279">P</offsets></italic><offsets xml_i="23143" xml_f="23172" txt_i="16279" txt_f="16305"> &lt; .043), general health (</offsets><italic><offsets xml_i="23180" xml_f="23181" txt_i="16305" txt_f="16306">P</offsets></italic><offsets xml_i="23190" xml_f="23213" txt_i="16306" txt_f="16326"> &lt; .039), vitality (</offsets><italic><offsets xml_i="23221" xml_f="23222" txt_i="16326" txt_f="16327">P</offsets></italic><offsets xml_i="23231" xml_f="23264" txt_i="16327" txt_f="16357"> &lt; .041) and social function (</offsets><italic><offsets xml_i="23272" xml_f="23273" txt_i="16357" txt_f="16358">P</offsets></italic><offsets xml_i="23282" xml_f="23436" txt_i="16358" txt_f="16509"> &lt; .029). The placebo group showed no significant changes versus baseline in SF-36 questionnaire dimensions. The groups differed in physical function (</offsets><italic><offsets xml_i="23444" xml_f="23445" txt_i="16509" txt_f="16510">P</offsets></italic><offsets xml_i="23454" xml_f="23482" txt_i="16510" txt_f="16535"> &lt; .009), physical role (</offsets><italic><offsets xml_i="23490" xml_f="23491" txt_i="16535" txt_f="16536">P</offsets></italic><offsets xml_i="23500" xml_f="23524" txt_i="16536" txt_f="16557"> &lt; .019), body pain (</offsets><italic><offsets xml_i="23532" xml_f="23533" txt_i="16557" txt_f="16558">P</offsets></italic><offsets xml_i="23542" xml_f="23571" txt_i="16558" txt_f="16584"> &lt; .036), general health (</offsets><italic><offsets xml_i="23579" xml_f="23580" txt_i="16584" txt_f="16585">P</offsets></italic><offsets xml_i="23589" xml_f="23612" txt_i="16585" txt_f="16605"> &lt; .048), vitality (</offsets><italic><offsets xml_i="23620" xml_f="23621" txt_i="16605" txt_f="16606">P</offsets></italic><offsets xml_i="23630" xml_f="23663" txt_i="16606" txt_f="16636"> &lt; .046) and social function (</offsets><italic><offsets xml_i="23671" xml_f="23672" txt_i="16636" txt_f="16637">P</offsets></italic><offsets xml_i="23681" xml_f="23694" txt_i="16637" txt_f="16647"> &lt; .028) (</offsets><xref ref-type="table" rid="tab2"><offsets xml_i="23728" xml_f="23735" txt_i="16647" txt_f="16654">Table 2</offsets></xref><offsets xml_i="23742" xml_f="23850" txt_i="16654" txt_f="16762">). The intervention group showed a significant overall improvement in Pittsburgh sleep quality index score (</offsets><italic><offsets xml_i="23858" xml_f="23859" txt_i="16762" txt_f="16763">P</offsets></italic><offsets xml_i="23868" xml_f="23942" txt_i="16763" txt_f="16834"> &lt; .043), and the groups differed significantly in the sleep duration (</offsets><italic><offsets xml_i="23950" xml_f="23951" txt_i="16834" txt_f="16835">P</offsets></italic><offsets xml_i="23960" xml_f="23995" txt_i="16835" txt_f="16867"> &lt; .042) and sleep disturbance (</offsets><italic><offsets xml_i="24003" xml_f="24004" txt_i="16867" txt_f="16868">P</offsets></italic><offsets xml_i="24013" xml_f="24032" txt_i="16868" txt_f="16884"> &lt; .040) items (</offsets><xref ref-type="table" rid="tab3"><offsets xml_i="24066" xml_f="24073" txt_i="16884" txt_f="16891">Table 3</offsets></xref><offsets xml_i="24080" xml_f="24084" txt_i="16891" txt_f="16895">). 
</offsets></p><p><offsets xml_i="24091" xml_f="24213" txt_i="16896" txt_f="17018">In the intervention group, significant correlations were found between trait anxiety and Beck depression inventory score (</offsets><italic><offsets xml_i="24221" xml_f="24222" txt_i="17018" txt_f="17019">r</offsets></italic><offsets xml_i="24231" xml_f="24241" txt_i="17019" txt_f="17029"> = 0.374; </offsets><italic><offsets xml_i="24249" xml_f="24250" txt_i="17029" txt_f="17030">P</offsets></italic><offsets xml_i="24259" xml_f="24304" txt_i="17030" txt_f="17075"> = .027), overall SF-36 score and VAS score (</offsets><italic><offsets xml_i="24312" xml_f="24313" txt_i="17075" txt_f="17076">r</offsets></italic><offsets xml_i="24322" xml_f="24332" txt_i="17076" txt_f="17086"> = 0.431; </offsets><italic><offsets xml_i="24340" xml_f="24341" txt_i="17086" txt_f="17087">P</offsets></italic><offsets xml_i="24350" xml_f="24401" txt_i="17087" txt_f="17138"> = .015), and between physical role and VAS score (</offsets><italic><offsets xml_i="24409" xml_f="24410" txt_i="17138" txt_f="17139">r</offsets></italic><offsets xml_i="24419" xml_f="24429" txt_i="17139" txt_f="17149"> = 0.564; </offsets><italic><offsets xml_i="24437" xml_f="24438" txt_i="17149" txt_f="17150">P</offsets></italic><offsets xml_i="24447" xml_f="24468" txt_i="17150" txt_f="17171"> = .021), body pain (</offsets><italic><offsets xml_i="24476" xml_f="24477" txt_i="17171" txt_f="17172">r</offsets></italic><offsets xml_i="24486" xml_f="24496" txt_i="17172" txt_f="17182"> = 0.378; </offsets><italic><offsets xml_i="24504" xml_f="24505" txt_i="17182" txt_f="17183">P</offsets></italic><offsets xml_i="24514" xml_f="24542" txt_i="17183" txt_f="17211"> = .016) and mental health (</offsets><italic><offsets xml_i="24550" xml_f="24551" txt_i="17211" txt_f="17212">r</offsets></italic><offsets xml_i="24560" xml_f="24570" txt_i="17212" txt_f="17222"> = 0.385; </offsets><italic><offsets xml_i="24578" xml_f="24579" txt_i="17222" txt_f="17223">P</offsets></italic><offsets xml_i="24588" xml_f="24597" txt_i="17223" txt_f="17232"> = .024).</offsets></p></sec><sec sec-type="subsection" id="sec3.2"><title><offsets xml_i="24653" xml_f="24686" txt_i="17234" txt_f="17267">3.2. Six Months Post-Intervention</offsets></title><p><offsets xml_i="24697" xml_f="24921" txt_i="17268" txt_f="17492">No significant intra-group or inter-group differences were found in state anxiety, depression or pain with respect to baseline. The intervention group showed a significant improvement (versus baseline) in physical function (</offsets><italic><offsets xml_i="24929" xml_f="24930" txt_i="17492" txt_f="17493">P</offsets></italic><offsets xml_i="24939" xml_f="25099" txt_i="17493" txt_f="17650"> &lt; .041). The placebo group showed no differences (versus baseline) in any SF-36 questionnaire item. The groups differed significantly in physical function (</offsets><italic><offsets xml_i="25107" xml_f="25108" txt_i="17650" txt_f="17651">P</offsets></italic><offsets xml_i="25117" xml_f="25143" txt_i="17651" txt_f="17674"> &lt; .049) and vitality (</offsets><italic><offsets xml_i="25151" xml_f="25152" txt_i="17674" txt_f="17675">P</offsets></italic><offsets xml_i="25161" xml_f="25232" txt_i="17675" txt_f="17743"> &lt; .050). The groups also differed significantly in sleep duration (</offsets><italic><offsets xml_i="25240" xml_f="25241" txt_i="17743" txt_f="17744">P</offsets></italic><offsets xml_i="25250" xml_f="25290" txt_i="17744" txt_f="17781"> &lt; .039), habitual sleep efficiency (</offsets><italic><offsets xml_i="25298" xml_f="25299" txt_i="17781" txt_f="17782">P</offsets></italic><offsets xml_i="25308" xml_f="25343" txt_i="17782" txt_f="17814"> &lt; .047) and sleep disturbance (</offsets><italic><offsets xml_i="25351" xml_f="25352" txt_i="17814" txt_f="17815">P</offsets></italic><offsets xml_i="25361" xml_f="25374" txt_i="17815" txt_f="17825"> &lt; .045) (</offsets><xref ref-type="table" rid="tab4"><offsets xml_i="25408" xml_f="25415" txt_i="17825" txt_f="17832">Table 4</offsets></xref><offsets xml_i="25422" xml_f="25424" txt_i="17832" txt_f="17834">).</offsets></p><p><offsets xml_i="25431" xml_f="25539" txt_i="17835" txt_f="17943">In the intervention group, correlations were found between overall SF-36 questionnaire score and VAS score (</offsets><italic><offsets xml_i="25547" xml_f="25548" txt_i="17943" txt_f="17944">r</offsets></italic><offsets xml_i="25557" xml_f="25567" txt_i="17944" txt_f="17954"> = 0.331; </offsets><italic><offsets xml_i="25575" xml_f="25576" txt_i="17954" txt_f="17955">P</offsets></italic><offsets xml_i="25585" xml_f="25653" txt_i="17955" txt_f="18023"> = .048) and between trait anxiety score and Beck depression score (</offsets><italic><offsets xml_i="25661" xml_f="25662" txt_i="18023" txt_f="18024">r</offsets></italic><offsets xml_i="25671" xml_f="25681" txt_i="18024" txt_f="18034"> = 0.323; </offsets><italic><offsets xml_i="25689" xml_f="25690" txt_i="18034" txt_f="18035">P</offsets></italic><offsets xml_i="25699" xml_f="25708" txt_i="18035" txt_f="18044"> = .045).</offsets></p></sec><sec sec-type="subsection" id="sec3.3"><title><offsets xml_i="25764" xml_f="25795" txt_i="18046" txt_f="18077">3.3. One Year Post-Intervention</offsets></title><p><offsets xml_i="25806" xml_f="25910" txt_i="18078" txt_f="18182">At 1 year, the intervention group showed a significant improvement (versus baseline) in sleep duration (</offsets><italic><offsets xml_i="25918" xml_f="25919" txt_i="18182" txt_f="18183">P</offsets></italic><offsets xml_i="25928" xml_f="25968" txt_i="18183" txt_f="18220"> &lt; .040), habitual sleep efficiency (</offsets><italic><offsets xml_i="25976" xml_f="25977" txt_i="18220" txt_f="18221">P</offsets></italic><offsets xml_i="25986" xml_f="26021" txt_i="18221" txt_f="18253"> &lt; .044) and daily dysfunction (</offsets><italic><offsets xml_i="26029" xml_f="26030" txt_i="18253" txt_f="18254">P</offsets></italic><offsets xml_i="26039" xml_f="26052" txt_i="18254" txt_f="18264"> &lt; .039) (</offsets><xref ref-type="table" rid="tab4"><offsets xml_i="26086" xml_f="26093" txt_i="18264" txt_f="18271">Table 4</offsets></xref><offsets xml_i="26100" xml_f="26239" txt_i="18271" txt_f="18410">). No significant differences in anxiety, depression, pain or quality of life were found between groups or with respect to baseline values.</offsets></p><p><offsets xml_i="26246" xml_f="26330" txt_i="18411" txt_f="18495">In the intervention group, trait anxiety was correlated with Beck depression score (</offsets><italic><offsets xml_i="26338" xml_f="26339" txt_i="18495" txt_f="18496">r</offsets></italic><offsets xml_i="26348" xml_f="26358" txt_i="18496" txt_f="18506"> = 0.311; </offsets><italic><offsets xml_i="26366" xml_f="26367" txt_i="18506" txt_f="18507">P</offsets></italic><offsets xml_i="26376" xml_f="26385" txt_i="18507" txt_f="18516"> = .047).</offsets></p></sec></sec><sec id="sec4"><title><offsets xml_i="26423" xml_f="26436" txt_i="18519" txt_f="18532">4. Discussion</offsets></title><p><offsets xml_i="26447" xml_f="26792" txt_i="18533" txt_f="18878">We examined the efficacy of craniosacral treatment on anxiety, depression and quality of life in patients with fibromyalgia. At 6 months after a 25-week treatment period, patients in the intervention group showed a significant improvement in their levels of state anxiety, trait anxiety, pain, quality of life and Pittsburgh sleep quality index.</offsets></p><p><offsets xml_i="26799" xml_f="26946" txt_i="18879" txt_f="19026">In comparative studies, patients with fibromyalgia have higher levels of depression in comparison to other patients with chronic diseases. Bennet [</offsets><xref rid="B41" ref-type="bibr"><offsets xml_i="26978" xml_f="26980" txt_i="19026" txt_f="19028">41</offsets></xref><offsets xml_i="26987" xml_f="27235" txt_i="19028" txt_f="19276">] found that 30% of patients with fibromyalgia present with depression at the first consultation and 60% at some time in their clinical history. These patients reported a diffuse non-localized pain that tended to increase their level of depression.</offsets></p><p><offsets xml_i="27242" xml_f="27479" txt_i="19277" txt_f="19514">Recent investigations have not considered depression to be a primary symptom of fibromyalgia, establishing that the degree of depression measured by the Beck questionnaire is closely related to the level of pain suffered by the patient [</offsets><xref rid="B42" ref-type="bibr"><offsets xml_i="27511" xml_f="27513" txt_i="19514" txt_f="19516">42</offsets></xref><offsets xml_i="27520" xml_f="27522" txt_i="19516" txt_f="19518">, </offsets><xref rid="B43" ref-type="bibr"><offsets xml_i="27554" xml_f="27556" txt_i="19518" txt_f="19520">43</offsets></xref><offsets xml_i="27563" xml_f="27738" txt_i="19520" txt_f="19695">]. Nonetheless, a variable percentage of fibromyalgia patients (30–70%) suffer depression, which is also present to some degree in any chronic disease that courses with pain [</offsets><xref rid="B44" ref-type="bibr"><offsets xml_i="27770" xml_f="27772" txt_i="19695" txt_f="19697">44</offsets></xref><offsets xml_i="27779" xml_f="27935" txt_i="19697" txt_f="19853">]. In multicenter studies, symptoms of major depression appear in 22–68% of patients affected by fibromyalgia, anxiety in 16% and simple phobias in 12–16% [</offsets><xref rid="B45" ref-type="bibr"><offsets xml_i="27967" xml_f="27969" txt_i="19853" txt_f="19855">45</offsets></xref><offsets xml_i="27976" xml_f="28195" txt_i="19855" txt_f="20074">]. It has not been established whether these psychological disorders are secondary to predominant fibromyalgia symptoms or are primary symptoms of the fibromyalgia syndrome itself, regardless of the remaining symptoms [</offsets><xref rid="B46" ref-type="bibr"><offsets xml_i="28227" xml_f="28229" txt_i="20074" txt_f="20076">46</offsets></xref><offsets xml_i="28236" xml_f="28237" txt_i="20076" txt_f="20077">–</offsets><xref rid="B48" ref-type="bibr"><offsets xml_i="28269" xml_f="28271" txt_i="20077" txt_f="20079">48</offsets></xref><offsets xml_i="28278" xml_f="28280" txt_i="20079" txt_f="20081">].</offsets></p><p><offsets xml_i="28287" xml_f="28661" txt_i="20082" txt_f="20456">Quality of life results showed a significant post-therapeutic improvement in the physical role, body pain and social function of the intervention group. These findings are consistent with multidisciplinary studies in patients with fibromyalgia, which have underlined the importance of motivation in achieving the participation of patients in the different therapy programs [</offsets><xref rid="B49" ref-type="bibr"><offsets xml_i="28693" xml_f="28695" txt_i="20456" txt_f="20458">49</offsets></xref><offsets xml_i="28702" xml_f="28703" txt_i="20458" txt_f="20459">–</offsets><xref rid="B52" ref-type="bibr"><offsets xml_i="28735" xml_f="28737" txt_i="20459" txt_f="20461">52</offsets></xref><offsets xml_i="28744" xml_f="28746" txt_i="20461" txt_f="20463">].</offsets></p><p><offsets xml_i="28753" xml_f="28966" txt_i="20464" txt_f="20677">The improvement in physical function achieved by our craniosacral therapy protocol was similar to that obtained by aerobic exercise programs in combination with other exercise modalities and educational programs [</offsets><xref rid="B53" ref-type="bibr"><offsets xml_i="28998" xml_f="29000" txt_i="20677" txt_f="20679">53</offsets></xref><offsets xml_i="29007" xml_f="29009" txt_i="20679" txt_f="20681">, </offsets><xref rid="B54" ref-type="bibr"><offsets xml_i="29041" xml_f="29043" txt_i="20681" txt_f="20683">54</offsets></xref><offsets xml_i="29050" xml_f="29330" txt_i="20683" txt_f="20963">]. Likewise, the improvement obtained in the majority of SF-36 dimensions was similar to that achieved after a 3-month hydrotherapy program, which obtained a 40% reduction in the “body pain" dimension, although the mechanisms underlying this improvement have not been elucidated [</offsets><xref rid="B55" ref-type="bibr"><offsets xml_i="29362" xml_f="29364" txt_i="20963" txt_f="20965">55</offsets></xref><offsets xml_i="29371" xml_f="29373" txt_i="20965" txt_f="20967">, </offsets><xref rid="B56" ref-type="bibr"><offsets xml_i="29405" xml_f="29407" txt_i="20967" txt_f="20969">56</offsets></xref><offsets xml_i="29414" xml_f="29416" txt_i="20969" txt_f="20971">].</offsets></p><p><offsets xml_i="29423" xml_f="29729" txt_i="20972" txt_f="21278">The improvement in the SF-36 questionnaire of quality of life shown by intervention group patients was lesser than their improvement in VAS score. This may be explained by the greater sensitivity of the “body pain" dimension of the SF-36 to detect painful changes in comparison to the VAS. Redondo et al. [</offsets><xref rid="B56" ref-type="bibr"><offsets xml_i="29761" xml_f="29763" txt_i="21278" txt_f="21280">56</offsets></xref><offsets xml_i="29770" xml_f="29869" txt_i="21280" txt_f="21379">] also reported significant differences in the results obtained by these two measures of body pain.</offsets></p><p><offsets xml_i="29876" xml_f="30289" txt_i="21380" txt_f="21793">At the end of the treatment period, the intervention and placebo groups differed significantly in overall Pittsburgh subjective sleep quality index score and in habitual sleep efficiency and sleep disturbance items. However, at one month after therapeutic intervention, significant differences were also found in sleep latency and duration. These results are in agreement with those published by Hains and Hains [</offsets><xref rid="B57" ref-type="bibr"><offsets xml_i="30321" xml_f="30323" txt_i="21793" txt_f="21795">57</offsets></xref><offsets xml_i="30330" xml_f="30674" txt_i="21795" txt_f="22139">], who also found significant differences in sleep quality at one month after a spinal compression and manipulation protocol despite finding no changes in fatigue or pain immediately after the treatment. An improvement in sleep quality persisted for 1 year after a 20-session course of manual therapy involving conjunctive tissue manipulation [</offsets><xref rid="B58" ref-type="bibr"><offsets xml_i="30706" xml_f="30708" txt_i="22139" txt_f="22141">58</offsets></xref><offsets xml_i="30715" xml_f="31079" txt_i="22141" txt_f="22505">]. The release of fascial restrictions may improve sleep quality by correcting visceral fascial dysfunction and thereby favoring the secretion of platelet serotonin. A study of the gut neurological system found that a high proportion of fibromyalgia patients had intestinal disorders, probably due to neuro-endocrinal causes, which may affect serotonin secretion [</offsets><xref rid="B59" ref-type="bibr"><offsets xml_i="31111" xml_f="31113" txt_i="22505" txt_f="22507">59</offsets></xref><offsets xml_i="31120" xml_f="31122" txt_i="22507" txt_f="22509">].</offsets></p><p><offsets xml_i="31129" xml_f="31296" txt_i="22510" txt_f="22677">Studies on the effects of aerobic exercise programs in fibromyalgia patients found no significant difference in the number of nights per week with sleep disturbances [</offsets><xref rid="B60" ref-type="bibr"><offsets xml_i="31328" xml_f="31330" txt_i="22677" txt_f="22679">60</offsets></xref><offsets xml_i="31337" xml_f="31338" txt_i="22679" txt_f="22680">–</offsets><xref rid="B62" ref-type="bibr"><offsets xml_i="31370" xml_f="31372" txt_i="22680" txt_f="22682">62</offsets></xref><offsets xml_i="31379" xml_f="31519" txt_i="22682" txt_f="22822">]. However, multidisciplinary therapeutic programs were reported to significantly improve anxiety, depression, wellbeing and sleep quality [</offsets><xref rid="B43" ref-type="bibr"><offsets xml_i="31551" xml_f="31553" txt_i="22822" txt_f="22824">43</offsets></xref><offsets xml_i="31560" xml_f="31562" txt_i="22824" txt_f="22826">].</offsets></p><p><offsets xml_i="31569" xml_f="32030" txt_i="22827" txt_f="23288">One of the limitations of the study was the inability to study 25 of the 376 patients in the accessible population before the randomized selection of the study group, due to incompatibility with their work schedules. A further limitation is related to the disparity between males and females diagnosed with fibromyalgia, which may be conditioned by the cultural setting. It is also possible that subjects with less severe pain were able to improve more rapidly.</offsets></p></sec><sec id="sec5"><title><offsets xml_i="32062" xml_f="32076" txt_i="23290" txt_f="23304">5. Conclusions</offsets></title><p></p></sec></body><back><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merayo-Alonso</surname><given-names>LA</given-names></name><name><surname>Cano-García</surname><given-names>FJ</given-names></name><name><surname>Rodríguez-Franco</surname><given-names>L</given-names></name><name><surname>Ariza-Ariza</surname><given-names>R</given-names></name><name><surname>Navarro-Sarabia</surname><given-names>F</given-names></name></person-group><article-title>Un acercamiento bibliométrico a la investigación en fibromialgia [A bibliometric approach to research into fibromyalgia]</article-title><source><italic>Reumatologia Clinica</italic></source><year>2007</year><volume>3</volume><issue>2</issue><fpage>55</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">21794399</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>S</given-names></name><name><surname>Tillisch</surname><given-names>K</given-names></name><name><surname>Mayer</surname><given-names>E</given-names></name></person-group><article-title>Functional somatic syndromes: emerging biomedical models and traditional Chinese medicine</article-title><source><italic>Evidence-Based Complementary and Alternative Medicine</italic></source><year>2004</year><volume>1</volume><fpage>35</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">15257324</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suhr</surname><given-names>JA</given-names></name></person-group><article-title>Neuropsychological impairment in fibromyalgia: relation to depression, fatigue, and pain</article-title><source><italic>Journal of Psychosomatic Research</italic></source><year>2003</year><volume>55</volume><issue>4</issue><fpage>321</fpage><lpage>329</lpage><pub-id pub-id-type="pmid">14507543</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macintyre</surname><given-names>A</given-names></name><name><surname>Hume</surname><given-names>MC</given-names></name></person-group><article-title>The chronic fatigue syndrome</article-title><source><italic>Postgraduate Medical Journal</italic></source><year>1993</year><volume>69</volume><issue>808</issue><fpage>p. 164</fpage></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudson</surname><given-names>JI</given-names></name><name><surname>Arnold</surname><given-names>LM</given-names></name><name><surname>Keck</surname><given-names>PE</given-names><suffix>Jr.</suffix></name><name><surname>Auchenbach</surname><given-names>MB</given-names></name><name><surname>Pope</surname><given-names>HG</given-names><suffix>Jr.</suffix></name></person-group><article-title>Family study of fibromyalgia and affective spectrum disorder</article-title><source><italic>Biological Psychiatry</italic></source><year>2004</year><volume>56</volume><issue>11</issue><fpage>884</fpage><lpage>891</lpage><pub-id pub-id-type="pmid">15576066</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gruber</surname><given-names>AJ</given-names></name><name><surname>Hudson</surname><given-names>JI</given-names></name><name><surname>Pope</surname><given-names>HG</given-names><suffix>Jr.</suffix></name></person-group><article-title>The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine: 
fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder</article-title><source><italic>Psychiatric Clinics of North America</italic></source><year>1996</year><volume>19</volume><issue>2</issue><fpage>351</fpage><lpage>369</lpage><pub-id pub-id-type="pmid">8827194</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Chaitow</surname><given-names>L</given-names></name></person-group><source><italic>Fibromyalgia Syndrome. A Practitioner’s Guide to Treatment</italic></source><year>2003</year><publisher-loc>London, UK</publisher-loc><publisher-name>Churchill Livingstone</publisher-name></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sletvold</surname><given-names>H</given-names></name><name><surname>Stiles</surname><given-names>TC</given-names></name><name><surname>Landro</surname><given-names>NI</given-names></name></person-group><article-title>Information processing in primary fibromyalgia, major depression and healthy controls</article-title><source><italic>Journal of Rheumatology</italic></source><year>1995</year><volume>22</volume><issue>1</issue><fpage>137</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">7699660</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>RF</given-names></name><name><surname>Meadows</surname><given-names>M-E</given-names></name><name><surname>Vincent</surname><given-names>LC</given-names></name><name><surname>Logigian</surname><given-names>EL</given-names></name><name><surname>Steere</surname><given-names>AC</given-names></name></person-group><article-title>Memory impairment and depression in patients with Lyme encephalopathy: comparison with fibromyalgia and nonpsychotically depressed patients</article-title><source><italic>Neurology</italic></source><year>1992</year><volume>42</volume><issue>7</issue><fpage>1263</fpage><lpage>1267</lpage><pub-id pub-id-type="pmid">1620329</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grace</surname><given-names>GM</given-names></name><name><surname>Nielson</surname><given-names>WR</given-names></name><name><surname>Hopkins</surname><given-names>M</given-names></name><name><surname>Berg</surname><given-names>MA</given-names></name></person-group><article-title>Concentration and memory deficits in patients with fibromyalgia syndrome</article-title><source><italic>Journal of Clinical and Experimental Neuropsychology</italic></source><year>1999</year><volume>21</volume><issue>4</issue><fpage>477</fpage><lpage>487</lpage><pub-id pub-id-type="pmid">10550807</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalgleish</surname><given-names>T</given-names></name><name><surname>Watts</surname><given-names>FN</given-names></name></person-group><article-title>Biases of attention and memory in disorders of anxiety and depresion</article-title><source><italic>Clinical Psychology Review</italic></source><year>1990</year><volume>10</volume><issue>5</issue><fpage>589</fpage><lpage>604</lpage></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>H</given-names></name><name><surname>Griffiths</surname><given-names>K</given-names></name><name><surname>Mackinnon</surname><given-names>A</given-names></name><name><surname>Jacomb</surname><given-names>P</given-names></name></person-group><article-title>A quantitative review of cognitive deficits in depression and Alzheimer-type dementia</article-title><source><italic>Journal of the International Neuropsychological Society</italic></source><year>1997</year><volume>3</volume><issue>6</issue><fpage>631</fpage><lpage>651</lpage><pub-id pub-id-type="pmid">9448376</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yardley</surname><given-names>L</given-names></name><name><surname>Redfern</surname><given-names>MS</given-names></name></person-group><article-title>Psychological factors influencing recovery from balance disorders</article-title><source><italic>Journal of Anxiety Disorders</italic></source><year>2001</year><volume>15</volume><issue>1-2</issue><fpage>107</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">11388354</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Peter</surname><given-names>D</given-names></name><name><surname>Chaitow</surname><given-names>L</given-names></name><name><surname>Harris</surname><given-names>G</given-names></name><name><surname>Morrison</surname><given-names>S</given-names></name></person-group><source><italic>Integrating Complementary Therapies in Primary Care</italic></source><year>2001</year><publisher-loc>Edinburgh, UK</publisher-loc><publisher-name>Churchill Livingstone</publisher-name></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martínez-Lavín</surname><given-names>M</given-names></name><name><surname>Hermosillo</surname><given-names>AG</given-names></name></person-group><article-title>Autonomic nervous system dysfunction may explain the multisystem features of fibromyalgia</article-title><source><italic>Seminars in Arthritis and Rheumatism</italic></source><year>2000</year><volume>29</volume><issue>4</issue><fpage>197</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">10707988</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martínez-Lavín</surname><given-names>M</given-names></name></person-group><article-title>Is fibromyalgia a generalized reflex sympathetic dystrophy?</article-title><source><italic>Clinical and Experimental Rheumatology</italic></source><year>2001</year><volume>19</volume><issue>1</issue><fpage>1</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">11247309</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katz</surname><given-names>RS</given-names></name><name><surname>Heard</surname><given-names>AR</given-names></name><name><surname>Mills</surname><given-names>M</given-names></name><name><surname>Leavitt</surname><given-names>F</given-names></name></person-group><article-title>The prevalence and clinical impact of reported cognitive difficulties (Fibrofog) in
patients with rheumatic disease with and without fibromyalgia</article-title><source><italic>Journal of Clinical Rheumatology</italic></source><year>2004</year><volume>10</volume><issue>2</issue><fpage>53</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">17043464</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sephton</surname><given-names>SE</given-names></name><name><surname>Studts</surname><given-names>JL</given-names></name><name><surname>Hoover</surname><given-names>K</given-names></name><etal></etal></person-group><article-title>Biological and psychological factors associated with memory function in fibromyalgia syndrome</article-title><source><italic>Health Psychology</italic></source><year>2003</year><volume>22</volume><issue>6</issue><fpage>592</fpage><lpage>597</lpage><pub-id pub-id-type="pmid">14640856</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dick</surname><given-names>BD</given-names></name><name><surname>Verrier</surname><given-names>MJ</given-names></name><name><surname>Harker</surname><given-names>KT</given-names></name><name><surname>Rashiq</surname><given-names>S</given-names></name></person-group><article-title>Disruption of cognitive function in fibromyalgia syndrome</article-title><source><italic>Pain</italic></source><year>2008</year><volume>139</volume><issue>3</issue><fpage>610</fpage><lpage>616</lpage><pub-id pub-id-type="pmid">18691816</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolfe</surname><given-names>F</given-names></name><name><surname>Smythe</surname><given-names>HA</given-names></name><name><surname>Yunus</surname><given-names>MB</given-names></name><etal></etal></person-group><article-title>The American College of Rheumatology 1990. Criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee</article-title><source><italic>Arthritis and Rheumatism</italic></source><year>1990</year><volume>33</volume><issue>2</issue><fpage>160</fpage><lpage>172</lpage><pub-id pub-id-type="pmid">2306288</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yunus</surname><given-names>MB</given-names></name><name><surname>Masi</surname><given-names>AT</given-names></name><name><surname>Aldag</surname><given-names>JC</given-names></name></person-group><article-title>A controlled study of primary fibromyalgia syndrome: clinical features and association with other functional syndromes</article-title><source><italic>Journal of Rheumatology</italic></source><year>1989</year><volume>16</volume><issue>19</issue><fpage>62</fpage><lpage>71</lpage></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaver</surname><given-names>JLF</given-names></name><name><surname>Lentz</surname><given-names>M</given-names></name><name><surname>Landis</surname><given-names>CA</given-names></name><name><surname>Heitkemper</surname><given-names>MM</given-names></name><name><surname>Buchwald</surname><given-names>DS</given-names></name><name><surname>Woods</surname><given-names>NF</given-names></name></person-group><article-title>Sleep, psychological distress, and stress arousal in women with fibromyalgia</article-title><source><italic>Research in Nursing and Health</italic></source><year>1997</year><volume>20</volume><issue>3</issue><fpage>247</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">9179178</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigatti</surname><given-names>SM</given-names></name><name><surname>Hernandez</surname><given-names>AM</given-names></name><name><surname>Cronan</surname><given-names>TA</given-names></name><name><surname>Rand</surname><given-names>KL</given-names></name></person-group><article-title>Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression</article-title><source><italic>Arthritis Care and Research</italic></source><year>2008</year><volume>59</volume><issue>7</issue><fpage>961</fpage><lpage>967</lpage><pub-id pub-id-type="pmid">18576297</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leza</surname><given-names>JC</given-names></name></person-group><article-title>Fibromyalgia: a challenge for neuroscience</article-title><source><italic>Revista de Neurologia</italic></source><year>2003</year><volume>36</volume><issue>12</issue><fpage>1165</fpage><lpage>1175</lpage><pub-id pub-id-type="pmid">12833238</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Backman</surname><given-names>CL</given-names></name></person-group><article-title>Arthritis and pain. Psychosocial aspects in the management of arthritis pain</article-title><source><italic>Arthritis Research and Therapy</italic></source><year>2006</year><volume>8, article 221</volume></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deluze</surname><given-names>C</given-names></name><name><surname>Bosia</surname><given-names>L</given-names></name><name><surname>Zirbs</surname><given-names>A</given-names></name><name><surname>Chantraine</surname><given-names>A</given-names></name><name><surname>Vischer</surname><given-names>TL</given-names></name></person-group><article-title>Electroacupuncture in fibromyalgia: results of a controlled trial</article-title><source><italic>British Medical Journal</italic></source><year>1992</year><volume>305</volume><issue>6864</issue><fpage>1249</fpage><lpage>1252</lpage><pub-id pub-id-type="pmid">1477566</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferraccioli</surname><given-names>G</given-names></name><name><surname>Ghirelli</surname><given-names>L</given-names></name><name><surname>Scita</surname><given-names>F</given-names></name><name><surname>Noili</surname><given-names>M</given-names></name><name><surname>Mozzam</surname><given-names>M</given-names></name><name><surname>Fontana</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>EMG-biofeedback training in fibromyalgia syndrome</article-title><source><italic>The Journal of Rheumatology</italic></source><year>1987</year><volume>14</volume><fpage>820</fpage><lpage>825</lpage><pub-id pub-id-type="pmid">3478492</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buckelew</surname><given-names>SP</given-names></name><name><surname>Conway</surname><given-names>R</given-names></name><name><surname>Parker</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Biofeedback/relaxation training and exercise interventions for fibromyalgia: a prospective trial</article-title><source><italic>Arthritis Care and Research</italic></source><year>1998</year><volume>11</volume><issue>3</issue><fpage>196</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">9782811</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huskisson</surname><given-names>EC</given-names></name><name><surname>Sturrock</surname><given-names>RD</given-names></name><name><surname>Tugwell</surname><given-names>P</given-names></name></person-group><article-title>Measurement of patient outcome</article-title><source><italic>British Journal of Rheumatology</italic></source><year>1983</year><volume>22</volume><issue>3</issue><fpage>86</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">6871597</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>González</surname><given-names>S</given-names></name><name><surname>Rodríguez</surname><given-names>M</given-names></name></person-group><person-group person-group-type="editor"><name><surname>González</surname><given-names>M</given-names></name></person-group><article-title>El dolor I: Fisiopatología. Tipos. Clínica. Sistemas de Medición</article-title><source><italic>Tratado de Medicina Paliativa y Tratamiento de Soporte en el enfermo con cáncer</italic></source><year>1996</year><publisher-loc>Madrid, Spain</publisher-loc><publisher-name>Panamerica</publisher-name></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Badia</surname><given-names>X</given-names></name><name><surname>Salmerón</surname><given-names>M</given-names></name><name><surname>Alonso</surname><given-names>J</given-names></name></person-group><article-title>La Medida de la Salud</article-title><source><italic>Measuring Health</italic></source><year>2005</year><publisher-loc>Barcelona, Spain</publisher-loc><publisher-name>Edimac</publisher-name></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buysse</surname><given-names>DJ</given-names></name><name><surname>Reynolds</surname><given-names>CF</given-names><suffix>III</suffix></name><name><surname>Monk</surname><given-names>TH</given-names></name><name><surname>Berman</surname><given-names>SR</given-names></name><name><surname>Kupfer</surname><given-names>DJ</given-names></name></person-group><article-title>The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research</article-title><source><italic>Psychiatry Research</italic></source><year>1989</year><volume>28</volume><issue>2</issue><fpage>193</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">2748771</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schotte</surname><given-names>CKW</given-names></name><name><surname>Maes</surname><given-names>M</given-names></name><name><surname>Cluydts</surname><given-names>R</given-names></name><name><surname>De Doncker</surname><given-names>D</given-names></name><name><surname>Cosyns</surname><given-names>P</given-names></name></person-group><article-title>Construct validity of the Beck Depression Inventory in a depressive population</article-title><source><italic>Journal of Affective Disorders</italic></source><year>1997</year><volume>46</volume><issue>2</issue><fpage>115</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">9479615</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lasa</surname><given-names>L</given-names></name><name><surname>Ayuso-Mateos</surname><given-names>JL</given-names></name><name><surname>Vázquez-Barquero</surname><given-names>JL</given-names></name><name><surname>Díez-Manrique</surname><given-names>FJ</given-names></name><name><surname>Dowrick</surname><given-names>CF</given-names></name></person-group><article-title>The use of the Beck Depression Inventory to screen for depression in the general population: a preliminary analysis</article-title><source><italic>Journal of Affective Disorders</italic></source><year>2000</year><volume>57</volume><issue>1–3</issue><fpage>261</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">10708841</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Spielberger</surname><given-names>CD</given-names></name></person-group><article-title>STAI. Cuestionario de Ansiedad Estado-Rasgo</article-title><source><italic>Questionnaire for State–Trait Anxiety</italic></source><year>2007</year><publisher-loc>Madrid, Spain</publisher-loc><publisher-name>TEA</publisher-name></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohn</surname><given-names>PM</given-names></name><name><surname>Macdonald</surname><given-names>JE</given-names></name></person-group><article-title>The survey of recent life experiences: a decontaminated hassles scale for adults</article-title><source><italic>Journal of Behavioral Medicine</italic></source><year>1992</year><volume>15</volume><issue>2</issue><fpage>221</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">1583682</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Upledger</surname><given-names>J</given-names></name></person-group><source><italic>Your Inner Physician and You &amp; CranioSacral Therapy</italic></source><year>1997</year><publisher-loc>Seattle, DC, USA</publisher-loc><publisher-name>Publishers Group West</publisher-name></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Upledger</surname><given-names>J</given-names></name><name><surname>Vredevoogd</surname><given-names>J</given-names></name></person-group><source><italic>Craniosacral Therapy</italic></source><year>1995</year><publisher-loc>Seattle, DC, USA</publisher-loc><publisher-name>Esatland Press</publisher-name></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Upledger</surname><given-names>J</given-names></name></person-group><source><italic>Somato Emotional Release</italic></source><year>2002</year><publisher-loc>Berkeley, UK</publisher-loc><publisher-name>North Atlantic Books</publisher-name></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Upledger</surname><given-names>J</given-names></name></person-group><article-title>Somato Emotional</article-title><source><italic>Release and Beyond</italic></source><year>1999</year><publisher-loc>Palm Beach Gardens, Fla, USA</publisher-loc><publisher-name>UI Publishing</publisher-name></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bennet</surname><given-names>R</given-names></name></person-group><source><italic>Rheumatic Disease Clinics of North America</italic></source><year>2002</year><publisher-loc>Philadelphia, DC, USA</publisher-loc><publisher-name>Saunders</publisher-name></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strobel</surname><given-names>E-S</given-names></name><name><surname>Wild</surname><given-names>J</given-names></name><name><surname>Müller</surname><given-names>W</given-names></name></person-group><article-title>Interdisciplinary group treatment for fibromyalgia</article-title><source><italic>Zeitschrift für Rheumatologie</italic></source><year>1998</year><volume>57</volume><issue>2</issue><fpage>89</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">9627947</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Astin</surname><given-names>JA</given-names></name><name><surname>Berman</surname><given-names>BM</given-names></name><name><surname>Bausell</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>W-L</given-names></name><name><surname>Hochberg</surname><given-names>M</given-names></name><name><surname>Forys</surname><given-names>KL</given-names></name></person-group><article-title>The efficacy of mindfulness meditation plus Qigong movement therapy in the treatment of fibromyalgia: a randomized controlled trial</article-title><source><italic>Journal of Rheumatology</italic></source><year>2003</year><volume>30</volume><issue>10</issue><fpage>2257</fpage><lpage>2262</lpage><pub-id pub-id-type="pmid">14528526</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kissel</surname><given-names>W</given-names></name><name><surname>Mahnig</surname><given-names>P</given-names></name></person-group><article-title>Fibromyalgia (generalizad tendomyopathy) in expert assesment. Analysis of 158 cases</article-title><source><italic>Praxis</italic></source><year>1998</year><volume>87</volume><fpage>538</fpage><lpage>545</lpage><pub-id pub-id-type="pmid">9600017</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epstein</surname><given-names>SA</given-names></name><name><surname>Kay</surname><given-names>G</given-names></name><name><surname>Clauw</surname><given-names>D</given-names></name><etal></etal></person-group><article-title>Psychiatric disorders in patients with fibromyalgia: a multicenter investigation</article-title><source><italic>Psychosomatics</italic></source><year>1999</year><volume>40</volume><issue>1</issue><fpage>57</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">9989122</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aaron</surname><given-names>LA</given-names></name><name><surname>Bradley</surname><given-names>LA</given-names></name><name><surname>Alarcón</surname><given-names>GS</given-names></name><etal></etal></person-group><article-title>Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness</article-title><source><italic>Arthritis and Rheumatism</italic></source><year>1996</year><volume>39</volume><issue>3</issue><fpage>436</fpage><lpage>445</lpage><pub-id pub-id-type="pmid">8607892</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okifuji</surname><given-names>A</given-names></name><name><surname>Turk</surname><given-names>DC</given-names></name><name><surname>Sherman</surname><given-names>JJ</given-names></name></person-group><article-title>Evaluation of the relationship between depression and fibromyalgia syndrome: why aren’t all patients depressed?</article-title><source><italic>Journal of Rheumatology</italic></source><year>2000</year><volume>27</volume><issue>1</issue><fpage>212</fpage><lpage>219</lpage><pub-id pub-id-type="pmid">10648041</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olivera</surname><given-names>FJ</given-names></name><name><surname>Maza</surname><given-names>C</given-names></name></person-group><article-title xml:lang="es">Culpabilidad y fibromialgia (Guilt and fibromyalgia)</article-title><source><italic>Aten Primaria</italic></source><year>2002</year><volume>30</volume><fpage>p. 534</fpage></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angst</surname><given-names>F</given-names></name><name><surname>Brioschi</surname><given-names>R</given-names></name><name><surname>Main</surname><given-names>CJ</given-names></name><name><surname>Lehmann</surname><given-names>S</given-names></name><name><surname>Aeschlimann</surname><given-names>A</given-names></name></person-group><article-title>Interdisciplinary rehabilitation in fibromyalgia and chronic back pain: a prospective outcome study</article-title><source><italic>Journal of Pain</italic></source><year>2006</year><volume>7</volume><issue>11</issue><fpage>807</fpage><lpage>815</lpage><pub-id pub-id-type="pmid">17074622</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gustafsson</surname><given-names>M</given-names></name><name><surname>Ekholm</surname><given-names>J</given-names></name><name><surname>Broman</surname><given-names>L</given-names></name></person-group><article-title>Effects of a multiprofessional rehabilitation programme for patients with fibromyalgia syndrome</article-title><source><italic>Journal of Rehabilitation Medicine</italic></source><year>2002</year><volume>34</volume><issue>3</issue><fpage>119</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">12395939</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hooten</surname><given-names>WM</given-names></name><name><surname>Townsend</surname><given-names>CO</given-names></name><name><surname>Sletten</surname><given-names>CD</given-names></name><name><surname>Bruce</surname><given-names>BK</given-names></name><name><surname>Rome</surname><given-names>JD</given-names></name></person-group><article-title>Treatment outcomes after multidisciplinary pain rehabilitation with analgesic medication withdrawal for patients with fibromyalgia</article-title><source><italic>Pain Medicine</italic></source><year>2007</year><volume>8</volume><issue>1</issue><fpage>8</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">17244099</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gard</surname><given-names>G</given-names></name></person-group><article-title>Body awareness therapy for patients with fibromyalgia and chronic pain</article-title><source><italic>Disability and Rehabilitation</italic></source><year>2005</year><volume>27</volume><issue>12</issue><fpage>725</fpage><lpage>728</lpage><pub-id pub-id-type="pmid">16012065</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicassio</surname><given-names>PM</given-names></name><name><surname>Radojevic</surname><given-names>V</given-names></name><name><surname>Weisman</surname><given-names>MH</given-names></name><etal></etal></person-group><article-title>A comparison of behavioral and educational interventions for fibromyalgia</article-title><source><italic>Journal of Rheumatology</italic></source><year>1997</year><volume>24</volume><issue>10</issue><fpage>2000</fpage><lpage>2007</lpage><pub-id pub-id-type="pmid">9330945</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramsay</surname><given-names>C</given-names></name><name><surname>Moreland</surname><given-names>J</given-names></name><name><surname>Ho</surname><given-names>M</given-names></name><name><surname>Joyce</surname><given-names>S</given-names></name><name><surname>Walker</surname><given-names>S</given-names></name><name><surname>Pullar</surname><given-names>T</given-names></name></person-group><article-title>An observer-blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia</article-title><source><italic>Rheumatology</italic></source><year>2000</year><volume>39</volume><issue>5</issue><fpage>501</fpage><lpage>505</lpage><pub-id pub-id-type="pmid">10852980</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mannerkorpi</surname><given-names>K</given-names></name><name><surname>Nyberg</surname><given-names>B</given-names></name><name><surname>Ahlmen</surname><given-names>M</given-names></name><name><surname>Ekdahl</surname><given-names>C</given-names></name></person-group><article-title>Pool exercise combined with an education program for patients with fibromyalgia syndrome. A prospective, randomized study</article-title><source><italic>Journal of Rheumatology</italic></source><year>2000</year><volume>27</volume><issue>10</issue><fpage>2473</fpage><lpage>2481</lpage><pub-id pub-id-type="pmid">11036846</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera Redondo</surname><given-names>J</given-names></name><name><surname>Moratalla Justo</surname><given-names>C</given-names></name><name><surname>Valdepeñas Moraleda</surname><given-names>F</given-names></name><etal></etal></person-group><article-title>Long-term efficacy of therapy in patients with fibromyalgia: a physical exercise-based program and a cognitive-behavioral approach</article-title><source><italic>Arthritis Care and Research</italic></source><year>2004</year><volume>51</volume><issue>2</issue><fpage>184</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">15077258</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hains</surname><given-names>G</given-names></name><name><surname>Hains</surname><given-names>F</given-names></name></person-group><article-title>Combined ischemic compression and spinal manipulation in the treatment of fibromyalgia: a preliminary estimate of dose and efficacy</article-title><source><italic>Journal of Manipulative and Physiological Therapeutics</italic></source><year>2000</year><volume>23</volume><issue>4</issue><fpage>225</fpage><lpage>230</lpage><pub-id pub-id-type="pmid">10820294</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Çitak-Karakaya</surname><given-names>I</given-names></name><name><surname>Akbayrak</surname><given-names>T</given-names></name><name><surname>Demirtürk</surname><given-names>F</given-names></name><name><surname>Ekici</surname><given-names>G</given-names></name><name><surname>Bakar</surname><given-names>Y</given-names></name></person-group><article-title>Short and long-term results a connective tissue manipulation and combined ultrasound therapy in patients with fibromyalgia</article-title><source><italic>Journal of Manipulative and Physiological Therapeutics</italic></source><year>2006</year><volume>29</volume><issue>7</issue><fpage>524</fpage><lpage>528</lpage><pub-id pub-id-type="pmid">16949941</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raj</surname><given-names>K</given-names></name><name><surname>Chandra</surname><given-names>TS</given-names></name><name><surname>Stanley</surname><given-names>MA</given-names></name></person-group><article-title>The enteric nervous system</article-title><source><italic>The New England Journal of Medicine</italic></source><year>1996</year><volume>43</volume><fpage>1106</fpage><lpage>1115</lpage></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCain</surname><given-names>GA</given-names></name><name><surname>Bell</surname><given-names>DA</given-names></name><name><surname>Mai</surname><given-names>FM</given-names></name><name><surname>Halliday</surname><given-names>PD</given-names></name></person-group><article-title>A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia</article-title><source><italic>Arthritis and Rheumatism</italic></source><year>1988</year><volume>31</volume><issue>9</issue><fpage>1135</fpage><lpage>1141</lpage><pub-id pub-id-type="pmid">3048273</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>L</given-names></name><name><surname>Nutting</surname><given-names>A</given-names></name><name><surname>MacIntosh</surname><given-names>BR</given-names></name><name><surname>Edworthy</surname><given-names>SM</given-names></name><name><surname>Butterwick</surname><given-names>D</given-names></name><name><surname>Cook</surname><given-names>J</given-names></name></person-group><article-title>An exercise program in the treatment of fibromyalgia</article-title><source><italic>Journal of Rheumatology</italic></source><year>1996</year><volume>23</volume><issue>6</issue><fpage>1050</fpage><lpage>1053</lpage><pub-id pub-id-type="pmid">8782139</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nørregaard</surname><given-names>J</given-names></name><name><surname>Bülow</surname><given-names>PM</given-names></name><name><surname>Lykkegaard</surname><given-names>JJ</given-names></name><name><surname>Mehlsen</surname><given-names>J</given-names></name><name><surname>Danneskiold-Samsøe</surname><given-names>B</given-names></name></person-group><article-title>Muscle strength, working capacity and effort in patients with fibromyalgia</article-title><source><italic>Scandinavian Journal of Rehabilitation Medicine</italic></source><year>1997</year><volume>29</volume><issue>2</issue><fpage>97</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">9198259</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Flow of participants in the study. None of the 84 participants reported adverse effects.</p></caption><graphic xlink:href="ECAM2011-178769.001"></graphic></fig><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Comparisons between study groups in levels of depression, anxiety and pain. *<italic>P</italic> = .05 (95% CI). Values are presented as means.</p></caption><graphic xlink:href="ECAM2011-178769.002"></graphic></fig><table-wrap id="tab1" position="float"><label>Table 1</label><caption><p>Baseline and demographic characteristics of study groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Characteristics</th><th align="center" rowspan="1" colspan="1">Intervention (<italic>n</italic> = 43)</th><th align="center" rowspan="1" colspan="1">Placebo (<italic>n</italic> = 41)</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age mean (SD)</td><td align="center" rowspan="1" colspan="1">48.25 (13.34)</td><td align="center" rowspan="1" colspan="1">52.26 (10.98)</td><td align="center" rowspan="1" colspan="1">.069</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex (%)</td><td align="center" rowspan="1" colspan="1">
</td><td align="center" rowspan="1" colspan="1">
</td><td align="center" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1"> Female</td><td align="center" rowspan="1" colspan="1">95.35</td><td align="center" rowspan="1" colspan="1">97.56</td><td align="center" rowspan="1" colspan="1">.529</td></tr><tr><td align="left" rowspan="1" colspan="1"> Male</td><td align="center" rowspan="1" colspan="1">4.65</td><td align="center" rowspan="1" colspan="1">2.44</td><td align="center" rowspan="1" colspan="1">.052</td></tr><tr><td align="left" rowspan="1" colspan="1">Aggravating factors (%)</td><td align="center" rowspan="1" colspan="1">
</td><td align="center" rowspan="1" colspan="1">
</td><td align="center" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1"> Emotional factors</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1"> Stress</td><td align="center" rowspan="1" colspan="1">42</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">.086</td></tr><tr><td align="left" rowspan="1" colspan="1"> Work involving standing</td><td align="center" rowspan="1" colspan="1">46.32</td><td align="center" rowspan="1" colspan="1">49.48</td><td align="center" rowspan="1" colspan="1">.194</td></tr><tr><td align="left" rowspan="1" colspan="1"> Cold</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1">Work activity (%)</td><td align="center" rowspan="1" colspan="1">
</td><td align="center" rowspan="1" colspan="1">
</td><td align="center" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1"> Full-time</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">.098</td></tr><tr><td align="left" rowspan="1" colspan="1"> Part-time</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">.067</td></tr><tr><td align="left" rowspan="1" colspan="1"> Sick leave</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">.051</td></tr><tr><td align="left" rowspan="1" colspan="1"> Unemployed</td><td align="center" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">.069</td></tr><tr><td align="left" rowspan="1" colspan="1">Diseases related to fibromyalgia syndrome (%)</td><td align="center" rowspan="1" colspan="1">
</td><td align="center" rowspan="1" colspan="1">
</td><td align="center" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1"> Arthritis</td><td align="center" rowspan="1" colspan="1">6.23</td><td align="center" rowspan="1" colspan="1">8.77</td><td align="center" rowspan="1" colspan="1">.119</td></tr><tr><td align="left" rowspan="1" colspan="1"> Chorea</td><td align="center" rowspan="1" colspan="1">2.13</td><td align="center" rowspan="1" colspan="1">3.87</td><td align="center" rowspan="1" colspan="1">.201</td></tr><tr><td align="left" rowspan="1" colspan="1"> Type I diabetes</td><td align="center" rowspan="1" colspan="1">3.25</td><td align="center" rowspan="1" colspan="1">5.75</td><td align="center" rowspan="1" colspan="1">.127</td></tr><tr><td align="left" rowspan="1" colspan="1"> Type II diabetes</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">.845</td></tr><tr><td align="left" rowspan="1" colspan="1"> Ulcerous colitis</td><td align="center" rowspan="1" colspan="1">6.5</td><td align="center" rowspan="1" colspan="1">3.5</td><td align="center" rowspan="1" colspan="1">.075</td></tr></tbody></table><table-wrap-foot><fn><p>
<italic>P</italic> = .05 between intervention and placebo groups.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab2" position="float"><label>Table 2</label><caption><p>Differences in quality of life (SF-36 questionnaire) between study groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">
</th><th align="center" colspan="2" rowspan="1">Baseline <italic>M</italic> (SD)</th><th align="left" rowspan="2" colspan="1">
<italic>P</italic>
Pre-T</th><th align="center" colspan="2" rowspan="1">25 weeks <italic>M</italic> (SD)</th><th align="left" rowspan="2" colspan="1">
<italic>P</italic>
1 <sup>(a)</sup>-PT</th><th align="center" colspan="2" rowspan="1">6 months <italic>M</italic> (SD))</th><th align="left" rowspan="2" colspan="1">
<italic>P</italic>
2 <sup>(a)</sup>-PT</th><th align="center" colspan="2" rowspan="1">1 year <italic>M</italic> (SD)</th><th align="left" rowspan="2" colspan="1">
<italic>P</italic>
3 <sup>(a)</sup>-PT</th></tr><tr><th align="left" rowspan="1" colspan="1">SF-36</th><th align="left" rowspan="1" colspan="1">IG</th><th align="left" rowspan="1" colspan="1">PG</th><th align="left" rowspan="1" colspan="1">IG</th><th align="left" rowspan="1" colspan="1">PG</th><th align="left" rowspan="1" colspan="1">IG</th><th align="left" rowspan="1" colspan="1">PG</th><th align="left" rowspan="1" colspan="1">IG</th><th align="left" rowspan="1" colspan="1">PG</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">PF</td><td align="left" rowspan="1" colspan="1">49.43 (6.90)</td><td align="left" rowspan="1" colspan="1">51.90 (9.92)</td><td align="left" rowspan="1" colspan="1">.199</td><td align="left" rowspan="1" colspan="1">45.90 (5.87)</td><td align="left" rowspan="1" colspan="1">50.53 (9.12)</td><td align="left" rowspan="1" colspan="1">.009*</td><td align="left" rowspan="1" colspan="1">46.05 (4.61)</td><td align="left" rowspan="1" colspan="1">49.05 (8.03)</td><td align="left" rowspan="1" colspan="1">.049*</td><td align="left" rowspan="1" colspan="1">47.43 (5.32)</td><td align="left" rowspan="1" colspan="1">50.68 (7.54)</td><td align="left" rowspan="1" colspan="1">.367</td></tr><tr><td align="left" rowspan="1" colspan="1">PR</td><td align="left" rowspan="1" colspan="1">25.17 (6.88)</td><td align="left" rowspan="1" colspan="1">25.86 (7.35)</td><td align="left" rowspan="1" colspan="1">.661</td><td align="left" rowspan="1" colspan="1">22.10 (6.84)</td><td align="left" rowspan="1" colspan="1">25.80 (6.98)</td><td align="left" rowspan="1" colspan="1">.019*</td><td align="left" rowspan="1" colspan="1">23.85 (7.05)</td><td align="left" rowspan="1" colspan="1">25.47 (7.09)</td><td align="left" rowspan="1" colspan="1">.067</td><td align="left" rowspan="1" colspan="1">24.67 (7.24)</td><td align="left" rowspan="1" colspan="1">26.01 (7.83)</td><td align="left" rowspan="1" colspan="1">.121</td></tr><tr><td align="left" rowspan="1" colspan="1">BP</td><td align="left" rowspan="1" colspan="1">75.76 (7.20)</td><td align="left" rowspan="1" colspan="1">78.43 (12.75)</td><td align="left" rowspan="1" colspan="1">.257</td><td align="left" rowspan="1" colspan="1">73.12 (6.08)</td><td align="left" rowspan="1" colspan="1">78.00 (13.07)</td><td align="left" rowspan="1" colspan="1">.036*</td><td align="left" rowspan="1" colspan="1">74.25 (6.74)</td><td align="left" rowspan="1" colspan="1">78.65 (13.22)</td><td align="left" rowspan="1" colspan="1">.052</td><td align="left" rowspan="1" colspan="1">74.84 (7.04)</td><td align="left" rowspan="1" colspan="1">77.39 (10.65)</td><td align="left" rowspan="1" colspan="1">.234</td></tr><tr><td align="left" rowspan="1" colspan="1">GH</td><td align="left" rowspan="1" colspan="1">67.02 (4.25)</td><td align="left" rowspan="1" colspan="1">68.28 (6.84)</td><td align="left" rowspan="1" colspan="1">.258</td><td align="left" rowspan="1" colspan="1">64.40 (4.65)</td><td align="left" rowspan="1" colspan="1">68.35 (6.39)</td><td align="left" rowspan="1" colspan="1">.048*</td><td align="left" rowspan="1" colspan="1">66.02 (4.12)</td><td align="left" rowspan="1" colspan="1">67.92 (6.69)</td><td align="left" rowspan="1" colspan="1">.087</td><td align="left" rowspan="1" colspan="1">66.72 (5.21)</td><td align="left" rowspan="1" colspan="1">67.63 (7.02)</td><td align="left" rowspan="1" colspan="1">.321</td></tr><tr><td align="left" rowspan="1" colspan="1">V</td><td align="left" rowspan="1" colspan="1">60.05 (5.23)</td><td align="left" rowspan="1" colspan="1">58.90 (6.27)</td><td align="left" rowspan="1" colspan="1">.376</td><td align="left" rowspan="1" colspan="1">62.73 (5.27)</td><td align="left" rowspan="1" colspan="1">59.48 (7.73)</td><td align="left" rowspan="1" colspan="1">.046*</td><td align="left" rowspan="1" colspan="1">60.80 (5.11)</td><td align="left" rowspan="1" colspan="1">58.72 (7.78)</td><td align="left" rowspan="1" colspan="1">.050*</td><td align="left" rowspan="1" colspan="1">61.34 (4.96)</td><td align="left" rowspan="1" colspan="1">59.01 (5.74)</td><td align="left" rowspan="1" colspan="1">.201</td></tr><tr><td align="left" rowspan="1" colspan="1">SF</td><td align="left" rowspan="1" colspan="1">63.23 (7.12)</td><td align="left" rowspan="1" colspan="1">63.93 (12.41)</td><td align="left" rowspan="1" colspan="1">.758</td><td align="left" rowspan="1" colspan="1">58.75 (6.74)</td><td align="left" rowspan="1" colspan="1">63.50 (11.57)</td><td align="left" rowspan="1" colspan="1">.028*</td><td align="left" rowspan="1" colspan="1">59.85 (10.93)</td><td align="left" rowspan="1" colspan="1">63.05 (11.87)</td><td align="left" rowspan="1" colspan="1">.075</td><td align="left" rowspan="1" colspan="1">60.45 (8.67)</td><td align="left" rowspan="1" colspan="1">64.45 (10.29)</td><td align="left" rowspan="1" colspan="1">.067</td></tr><tr><td align="left" rowspan="1" colspan="1">RE</td><td align="left" rowspan="1" colspan="1">49.18 (7.65)</td><td align="left" rowspan="1" colspan="1">46.35 (5.69)</td><td align="left" rowspan="1" colspan="1">.065</td><td align="left" rowspan="1" colspan="1">45.60 (7.85)</td><td align="left" rowspan="1" colspan="1">47.23 (5.66)</td><td align="left" rowspan="1" colspan="1">.292</td><td align="left" rowspan="1" colspan="1">49.65 (6.52)</td><td align="left" rowspan="1" colspan="1">46.40 (5.96)</td><td align="left" rowspan="1" colspan="1">.053</td><td align="left" rowspan="1" colspan="1">48.33 (8.31)</td><td align="left" rowspan="1" colspan="1">47.42 (7.29)</td><td align="left" rowspan="1" colspan="1">.135</td></tr><tr><td align="left" rowspan="1" colspan="1">MH</td><td align="left" rowspan="1" colspan="1">76.65 (11.23)</td><td align="left" rowspan="1" colspan="1">80.60 (9.66)</td><td align="left" rowspan="1" colspan="1">.097</td><td align="left" rowspan="1" colspan="1">77.48 (8.73)</td><td align="left" rowspan="1" colspan="1">81.15 (10.42)</td><td align="left" rowspan="1" colspan="1">.069</td><td align="left" rowspan="1" colspan="1">74.15 (12.12)</td><td align="left" rowspan="1" colspan="1">77.80 (7.84)</td><td align="left" rowspan="1" colspan="1">.074</td><td align="left" rowspan="1" colspan="1">75.64 (9.86)</td><td align="left" rowspan="1" colspan="1">79.45 (10.35)</td><td align="left" rowspan="1" colspan="1">.083</td></tr></tbody></table><table-wrap-foot><fn><p>Values are presented as means and standard deviations (SD). IG, intervention group; PG, placebo group; Pre-T, pre-therapy; 1 <sup>(a)</sup> PT, post-therapy after 25 weeks of treatment; 2 <sup>(a)</sup> PT, post-therapy at 6 months after end of treatment; 3 <sup>(a)</sup> PT, post-therapy at 1 year after end of treatment; PF, physical function; PR, physical role; BP, body pain; GH, general health; V, vitality; SF, social function; ER, emotional role; MH, mental health. *<italic>P</italic> = .05 (95% CI).</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab3" position="float"><label>Table 3</label><caption><p>Differences between study groups in Pittsburgh sleep quality index score at baseline and after therapy.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">
</th><th align="center" colspan="6" rowspan="1">Baseline (<italic>n</italic>)</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
</th><th align="center" colspan="6" rowspan="1">25 weeks (<italic>n</italic>)</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
</th></tr><tr><th align="left" rowspan="1" colspan="1">
</th><th align="center" colspan="3" rowspan="1">IG</th><th align="center" colspan="3" rowspan="1">PG</th><th align="center" rowspan="1" colspan="1">Pre-T</th><th align="center" colspan="3" rowspan="1">IG</th><th align="center" colspan="3" rowspan="1">PG</th><th align="center" rowspan="1" colspan="1">1 <sup>(a)</sup>-PT</th></tr><tr><th align="left" rowspan="1" colspan="1">PSQI</th><th align="center" rowspan="1" colspan="1">NP</th><th align="center" rowspan="1" colspan="1">MP</th><th align="center" rowspan="1" colspan="1">SP</th><th align="center" rowspan="1" colspan="1">NP</th><th align="center" rowspan="1" colspan="1">MP</th><th align="center" rowspan="1" colspan="1">SP</th><th align="center" rowspan="1" colspan="1">
</th><th align="center" rowspan="1" colspan="1">NP</th><th align="center" rowspan="1" colspan="1">MP</th><th align="center" rowspan="1" colspan="1">SP</th><th align="center" rowspan="1" colspan="1">NP</th><th align="center" rowspan="1" colspan="1">MP</th><th align="center" rowspan="1" colspan="1">SP</th><th align="center" rowspan="1" colspan="1">
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">PSQ</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">.064</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">.043*</td></tr><tr><td align="left" rowspan="1" colspan="1">SL</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">.948</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">.064</td></tr><tr><td align="left" rowspan="1" colspan="1">SD</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">.059</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">.042*</td></tr><tr><td align="left" rowspan="1" colspan="1">HSE</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">.255</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">.065</td></tr><tr><td align="left" rowspan="1" colspan="1">SDI</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">.191</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">.040*</td></tr><tr><td align="left" rowspan="1" colspan="1">DD</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">.592</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">.065</td></tr></tbody></table><table-wrap-foot><fn><p>Values are shown as <italic>n</italic> = number of patients with no problems, moderate problems, severe problems. PSQI, Pittsburgh sleep quality index; IG, intervention group; PG, placebo group; Pre-T, pre-therapeutic; 1 <sup>(a)</sup> PT, post-therapy (after 25 weeks of treatment); PSQ, Pittsburgh subjective quality; SL, sleep latency; SD, sleep duration; HSE, habitual sleep efficiency; SDI, sleep disturbance; DD, daily dysfunction; NP, no problems; MP, moderate problems; SP, severe problems. *<italic>P</italic> = .05 (95% CI).</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab4" position="float"><label>Table 4</label><caption><p>Differences between study groups in Pittsburgh sleep quality index at 6 months and 1 year after treatment.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">
</th><th align="center" colspan="6" rowspan="1">6 months (<italic>n</italic> = number of patients)</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
</th><th align="center" colspan="6" rowspan="1">1 year (<italic>n</italic> = number of patients)</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
</th></tr><tr><th align="left" rowspan="1" colspan="1">
</th><th align="center" colspan="3" rowspan="1">IG</th><th align="center" colspan="3" rowspan="1">PG</th><th align="center" rowspan="1" colspan="1">2 <sup>(a)</sup>-PT</th><th align="center" colspan="3" rowspan="1">IG</th><th align="center" colspan="3" rowspan="1">PG</th><th align="center" rowspan="1" colspan="1">3 <sup>(a)</sup>-PT</th></tr><tr><th align="left" rowspan="1" colspan="1">PSQI</th><th align="center" rowspan="1" colspan="1">NP</th><th align="center" rowspan="1" colspan="1">MP</th><th align="center" rowspan="1" colspan="1">SP</th><th align="center" rowspan="1" colspan="1">NP</th><th align="center" rowspan="1" colspan="1">MP</th><th align="center" rowspan="1" colspan="1">SP</th><th align="center" rowspan="1" colspan="1">
</th><th align="center" rowspan="1" colspan="1">NP</th><th align="center" rowspan="1" colspan="1">MP</th><th align="center" rowspan="1" colspan="1">SP</th><th align="center" rowspan="1" colspan="1">NP</th><th align="center" rowspan="1" colspan="1">MP</th><th align="center" rowspan="1" colspan="1">SP</th><th align="center" rowspan="1" colspan="1">
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">PSQ</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">.093</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">.054</td></tr><tr><td align="left" rowspan="1" colspan="1">SL</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">.105</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">.132</td></tr><tr><td align="left" rowspan="1" colspan="1">SD</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">.039*</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">.040*</td></tr><tr><td align="left" rowspan="1" colspan="1">HSE</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">.047*</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">.044*</td></tr><tr><td align="left" rowspan="1" colspan="1">SDI</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">.045*</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">.088</td></tr><tr><td align="left" rowspan="1" colspan="1">DD</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">.240</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">.039*</td></tr></tbody></table><table-wrap-foot><fn><p>Values are shown as <italic>n</italic> = number of patients with no problems, moderate problems, severe problems. PSQI, Pittsburgh sleep quality index; IG, intervention group; PG, placebo group; Pre-T, pre-therapy; 2 <sup>(a)</sup> PT, post-therapy at 6 months after end of treatment; 3 <sup>(a)</sup> PT, post-therapy at 1 year after end of treatment; PSQ, Pittsburgh subjective quality; SL, sleep latency; SD, sleep duration; HSE, habitual sleep efficiency; SDI, sleep disturbance; DD, daily dysfunction; NP, does not present problems; MP, moderate problems; SP, severe problems. *<italic>P</italic> = .05 (95% CI).</p></fn></table-wrap-foot></table-wrap></floats-group></article>